메뉴 건너뛰기




Volumn 18, Issue 11, 2017, Pages e653-e706

Future cancer research priorities in the USA: a Lancet Oncology Commission

(54)  Jaffee, Elizabeth M a   Dang, Chi Van b,c   Agus, David B d   Alexander, Brian M e   Anderson, Kenneth C e   Ashworth, Alan g   Barker, Anna D h   Bastani, Roshan i   Bhatia, Sangeeta j   Bluestone, Jeffrey A g,k   Brawley, Otis l   Butte, Atul J g   Coit, Daniel G m   Davidson, Nancy E n   Davis, Mark o   DePinho, Ronald A p   Diasio, Robert B q   Draetta, Giulio p   Frazier, A Lindsay e   Futreal, Andrew p   more..


Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; IMMUNOLOGICAL ANTINEOPLASTIC AGENT; TUMOR MARKER;

EID: 85032672086     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30698-8     Document Type: Review
Times cited : (158)

References (402)
  • 1
    • 85013388313 scopus 로고    scopus 로고
    • Cancer Moonshot. Blue Ribbon Panel Report
    • (accessed Sept 30, 2017).
    • National Cancer Institute. Cancer Moonshot. Blue Ribbon Panel Report. https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/blue-ribbon-panel-report-2016.pdf, 2016 (accessed Sept 30, 2017).
    • (2016)
  • 2
    • 84973467506 scopus 로고    scopus 로고
    • Aiming high—changing the trajectory for cancer
    • Lowy, DR, Collins, FS, Aiming high—changing the trajectory for cancer. N Engl J Med 374 (2016), 1901–1904.
    • (2016) N Engl J Med , vol.374 , pp. 1901-1904
    • Lowy, D.R.1    Collins, F.S.2
  • 4
    • 85015642839 scopus 로고    scopus 로고
    • Realizing the potential of cancer prevention—the role of implementation science
    • Emmons, KM, Colditz, GA, Realizing the potential of cancer prevention—the role of implementation science. N Engl J Med 376 (2017), 986–990.
    • (2017) N Engl J Med , vol.376 , pp. 986-990
    • Emmons, K.M.1    Colditz, G.A.2
  • 5
    • 85029706147 scopus 로고    scopus 로고
    • Physical activity, sedentary behavior, diet, and cancer: an update and emerging new evidence
    • Kerr, J, Anderson, CA, Lippman, SM, Physical activity, sedentary behavior, diet, and cancer: an update and emerging new evidence. Lancet Oncol 18 (2017), e457–e471.
    • (2017) Lancet Oncol , vol.18 , pp. e457-e471
    • Kerr, J.1    Anderson, C.A.2    Lippman, S.M.3
  • 6
    • 85016324008 scopus 로고    scopus 로고
    • Interaction landscape of inherited polymorphisms with somatic events in cancer
    • Carter, H, Marty, R, Hofree, M, et al. Interaction landscape of inherited polymorphisms with somatic events in cancer. Cancer Discov 7 (2017), 410–423.
    • (2017) Cancer Discov , vol.7 , pp. 410-423
    • Carter, H.1    Marty, R.2    Hofree, M.3
  • 7
    • 84969965544 scopus 로고    scopus 로고
    • Association of leisure–time physical activity with risk of 26 types of cancer in 1.44 million adults
    • Moore, SC, Lee, IM, Weiderpass, E, et al. Association of leisure–time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 176 (2016), 816–825.
    • (2016) JAMA Intern Med , vol.176 , pp. 816-825
    • Moore, S.C.1    Lee, I.M.2    Weiderpass, E.3
  • 8
    • 84960099239 scopus 로고    scopus 로고
    • The impact of physical activity on health–related fitness and quality of life for patients with head and neck cancer: a systematic review
    • Capozzi, LC, Nishimura, KC, McNeely, ML, Lau, H, Culos–Reed, SN, The impact of physical activity on health–related fitness and quality of life for patients with head and neck cancer: a systematic review. Br J Sports Med 50 (2016), 325–338.
    • (2016) Br J Sports Med , vol.50 , pp. 325-338
    • Capozzi, L.C.1    Nishimura, K.C.2    McNeely, M.L.3    Lau, H.4    Culos-Reed, S.N.5
  • 10
    • 84979734815 scopus 로고    scopus 로고
    • Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women
    • Ekelund, U, Steene-Johannessen, J, Brown, WJ, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet 388 (2016), 1302–1310.
    • (2016) Lancet , vol.388 , pp. 1302-1310
    • Ekelund, U.1    Steene-Johannessen, J.2    Brown, W.J.3
  • 11
    • 85017497120 scopus 로고    scopus 로고
    • Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
    • Di Daniele, N, Noce, A, Vidiri, MF, et al. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget 8 (2017), 8947–8979.
    • (2017) Oncotarget , vol.8 , pp. 8947-8979
    • Di Daniele, N.1    Noce, A.2    Vidiri, M.F.3
  • 12
    • 23744506376 scopus 로고    scopus 로고
    • Intensive lifestyle changes may affect the progression of prostate cancer
    • Ornish, D, Weidner, G, Fair, WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174 (2005), 1065–1070.
    • (2005) J Urol , vol.174 , pp. 1065-1070
    • Ornish, D.1    Weidner, G.2    Fair, W.R.3
  • 13
    • 54349098423 scopus 로고    scopus 로고
    • Increased telomerase activity and comprehensive lifestyle changes: a pilot study
    • Ornish, D, Lin, J, Daubenmier, J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 9 (2008), 1048–1057.
    • (2008) Lancet Oncol , vol.9 , pp. 1048-1057
    • Ornish, D.1    Lin, J.2    Daubenmier, J.3
  • 14
    • 84884700070 scopus 로고    scopus 로고
    • Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study
    • Ornish, D, Lin, J, Chan, JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14 (2013), 1112–1120.
    • (2013) Lancet Oncol , vol.14 , pp. 1112-1120
    • Ornish, D.1    Lin, J.2    Chan, J.M.3
  • 15
    • 0032539162 scopus 로고    scopus 로고
    • Intensive lifestyle changes for reversal of coronary heart disease
    • Ornish, D, Scherwitz, LW, Billings, JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280 (1998), 2001–2007.
    • (1998) JAMA , vol.280 , pp. 2001-2007
    • Ornish, D.1    Scherwitz, L.W.2    Billings, J.H.3
  • 16
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 17
    • 77955845440 scopus 로고    scopus 로고
    • The power of exercise: buffering the effect of chronic stress on telomere length
    • Puterman, E, Lin, J, Blackburn, E, O'Donovan, A, Adler, N, Epel, E, The power of exercise: buffering the effect of chronic stress on telomere length. PLoS One, 5, 2010, e10837.
    • (2010) PLoS One , vol.5 , pp. e10837
    • Puterman, E.1    Lin, J.2    Blackburn, E.3    O'Donovan, A.4    Adler, N.5    Epel, E.6
  • 18
    • 84941774531 scopus 로고    scopus 로고
    • Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality
    • Yang, M, Kenfield, SA, Van Blarigan, EL, et al. Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality. Cancer Prev Res 8 (2015), 545–551.
    • (2015) Cancer Prev Res , vol.8 , pp. 545-551
    • Yang, M.1    Kenfield, S.A.2    Van Blarigan, E.L.3
  • 19
    • 84953897523 scopus 로고    scopus 로고
    • Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort
    • Emaus, MJ, Peeters, PH, Bakker, MF, et al. Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort. Am J Clin Nutr 103 (2016), 168–177.
    • (2016) Am J Clin Nutr , vol.103 , pp. 168-177
    • Emaus, M.J.1    Peeters, P.H.2    Bakker, M.F.3
  • 20
    • 84873600352 scopus 로고    scopus 로고
    • Fruit and vegetable intake and risk of breast cancer by hormone receptor status
    • Jung, S, Spiegelman, D, Baglietto, L, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 105 (2013), 219–236.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 219-236
    • Jung, S.1    Spiegelman, D.2    Baglietto, L.3
  • 21
    • 84969808380 scopus 로고    scopus 로고
    • Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study
    • Farvid, MS, Chen, WY, Michels, KB, Cho, E, Willett, WC, Eliassen, AH, Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study. BMJ, 353, 2016, i2343.
    • (2016) BMJ , vol.353 , pp. i2343
    • Farvid, M.S.1    Chen, W.Y.2    Michels, K.B.3    Cho, E.4    Willett, W.C.5    Eliassen, A.H.6
  • 22
    • 84946147457 scopus 로고    scopus 로고
    • Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial
    • Toledo, E, Salas-Salvado, J, Donat-Vargas, C, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 175 (2015), 1752–1760.
    • (2015) JAMA Intern Med , vol.175 , pp. 1752-1760
    • Toledo, E.1    Salas-Salvado, J.2    Donat-Vargas, C.3
  • 24
    • 84895727751 scopus 로고    scopus 로고
    • Low protein intake is associated with a major reduction in IGF–1, cancer, and overall mortality in the 65 and younger but not older population
    • Levine, ME, Suarez, JA, Brandhorst, S, et al. Low protein intake is associated with a major reduction in IGF–1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 19 (2014), 407–417.
    • (2014) Cell Metab , vol.19 , pp. 407-417
    • Levine, M.E.1    Suarez, J.A.2    Brandhorst, S.3
  • 25
    • 84920895872 scopus 로고    scopus 로고
    • A red meat-derived glycan promotes inflammation and cancer progression
    • Samraj, AN, Pearce, OM, Laubli, H, et al. A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci USA 112 (2015), 542–547.
    • (2015) Proc Natl Acad Sci USA , vol.112 , pp. 542-547
    • Samraj, A.N.1    Pearce, O.M.2    Laubli, H.3
  • 26
    • 84978115999 scopus 로고    scopus 로고
    • The microbiome and innate immunity
    • Thaiss, CA, Zmora, N, Levy, M, Elinav, E, The microbiome and innate immunity. Nature 535 (2016), 65–74.
    • (2016) Nature , vol.535 , pp. 65-74
    • Thaiss, C.A.1    Zmora, N.2    Levy, M.3    Elinav, E.4
  • 27
    • 85017381640 scopus 로고    scopus 로고
    • Association of dietary patterns with risk of colorectal cancer subtypes classified by fusobacterium nucleatum in tumor tissue
    • Mehta, RS, Nishihara, R, Cao, Y, et al. Association of dietary patterns with risk of colorectal cancer subtypes classified by fusobacterium nucleatum in tumor tissue. JAMA Oncol 3 (2017), 921–927.
    • (2017) JAMA Oncol , vol.3 , pp. 921-927
    • Mehta, R.S.1    Nishihara, R.2    Cao, Y.3
  • 28
    • 84885634549 scopus 로고    scopus 로고
    • Metabolic syndrome: F stands for fructose and fat
    • Lyssiotis, CA, Cantley, LC, Metabolic syndrome: F stands for fructose and fat. Nature 502 (2013), 181–182.
    • (2013) Nature , vol.502 , pp. 181-182
    • Lyssiotis, C.A.1    Cantley, L.C.2
  • 29
    • 84942792026 scopus 로고    scopus 로고
    • Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk
    • Murphy, EA, Velazquez, KT, Herbert, KM, Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care 18 (2015), 515–520.
    • (2015) Curr Opin Clin Nutr Metab Care , vol.18 , pp. 515-520
    • Murphy, E.A.1    Velazquez, K.T.2    Herbert, K.M.3
  • 30
    • 85017373900 scopus 로고    scopus 로고
    • Gut microbiota promotes obesity–associated liver cancer through pge2–mediated suppression of antitumor immunity
    • Loo, TM, Kamachi, F, Watanabe, Y, et al. Gut microbiota promotes obesity–associated liver cancer through pge2–mediated suppression of antitumor immunity. Cancer Discov 7 (2017), 522–538.
    • (2017) Cancer Discov , vol.7 , pp. 522-538
    • Loo, T.M.1    Kamachi, F.2    Watanabe, Y.3
  • 31
    • 85004115511 scopus 로고    scopus 로고
    • Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis
    • Kettner, NM, Voicu, H, Finegold, MJ, et al. Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis. Cancer Cell 30 (2016), 909–924.
    • (2016) Cancer Cell , vol.30 , pp. 909-924
    • Kettner, N.M.1    Voicu, H.2    Finegold, M.J.3
  • 32
    • 84929266699 scopus 로고    scopus 로고
    • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
    • Neuschwander-Tetri, BA, Loomba, R, Sanyal, AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385 (2015), 956–965.
    • (2015) Lancet , vol.385 , pp. 956-965
    • Neuschwander-Tetri, B.A.1    Loomba, R.2    Sanyal, A.J.3
  • 33
    • 84987802495 scopus 로고    scopus 로고
    • Erlotinib and the risk of oral cancer: the Erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial
    • William, WN Jr, Papadimitrakopoulou, V, Lee, JJ, et al. Erlotinib and the risk of oral cancer: the Erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial. JAMA Oncol 2 (2016), 209–216.
    • (2016) JAMA Oncol , vol.2 , pp. 209-216
    • William, W.N.1    Papadimitrakopoulou, V.2    Lee, J.J.3
  • 34
    • 84976582488 scopus 로고    scopus 로고
    • Oral cancer chemoprevention–the end of EPOC, the beginning of an epoch of molecular selection
    • Bauman, JE, Grandis, J, Oral cancer chemoprevention–the end of EPOC, the beginning of an epoch of molecular selection. JAMA Oncol 2 (2016), 178–179.
    • (2016) JAMA Oncol , vol.2 , pp. 178-179
    • Bauman, J.E.1    Grandis, J.2
  • 35
    • 84982766646 scopus 로고    scopus 로고
    • Immune-modulation by epidermal growth factor receptor inhibitors: implication on anti–tumor immunity in lung cancer
    • Im, JS, Herrmann, AC, Bernatchez, C, et al. Immune-modulation by epidermal growth factor receptor inhibitors: implication on anti–tumor immunity in lung cancer. PLoS One, 11, 2016, e0160004.
    • (2016) PLoS One , vol.11 , pp. e0160004
    • Im, J.S.1    Herrmann, A.C.2    Bernatchez, C.3
  • 36
    • 85036497908 scopus 로고    scopus 로고
    • Immune profiling of oral pre-malignant lesions (OPLs): an Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis
    • William, WN Jr, Uraoka, N, Peng, SA, et al. Immune profiling of oral pre-malignant lesions (OPLs): an Erlotinib Prevention of Oral Cancer (EPOC) study biobank analysis. J Clin Oncol, 35(suppl), 2017, 1545.
    • (2017) J Clin Oncol , vol.35 , pp. 1545
    • William, W.N.1    Uraoka, N.2    Peng, S.A.3
  • 37
    • 85010679719 scopus 로고    scopus 로고
    • Population-wide impact of long-term use of aspirin and the risk for cancer
    • Cao, Y, Nishihara, R, Wu, K, et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol 2 (2016), 762–769.
    • (2016) JAMA Oncol , vol.2 , pp. 762-769
    • Cao, Y.1    Nishihara, R.2    Wu, K.3
  • 38
    • 84959516180 scopus 로고    scopus 로고
    • Aspirin and colorectal cancer: the promise of precision chemoprevention
    • Drew, DA, Cao, Y, Chan, AT, Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer 16 (2016), 173–186.
    • (2016) Nat Rev Cancer , vol.16 , pp. 173-186
    • Drew, D.A.1    Cao, Y.2    Chan, A.T.3
  • 39
    • 84952660923 scopus 로고    scopus 로고
    • Where do we stand with aspirin for the prevention of colorectal cancer? The USPSTF recommendations
    • Chan, AT, Ladabaum, U, Where do we stand with aspirin for the prevention of colorectal cancer? The USPSTF recommendations. Gastroenterology 150 (2016), 14–18.
    • (2016) Gastroenterology , vol.150 , pp. 14-18
    • Chan, A.T.1    Ladabaum, U.2
  • 40
    • 84899547782 scopus 로고    scopus 로고
    • Aspirin and the risk of colorectal cancer in relation to the expression of 15–hydroxyprostaglandin dehydrogenase (HPGD)
    • Fink, SP, Yamauchi, M, Nishihara, R, et al. Aspirin and the risk of colorectal cancer in relation to the expression of 15–hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med, 6, 2014, 233re2.
    • (2014) Sci Transl Med , vol.6 , pp. 233re2
    • Fink, S.P.1    Yamauchi, M.2    Nishihara, R.3
  • 41
    • 84892607343 scopus 로고    scopus 로고
    • Realizing the promise of cancer predisposition genes
    • Rahman, N, Realizing the promise of cancer predisposition genes. Nature 505 (2014), 302–308.
    • (2014) Nature , vol.505 , pp. 302-308
    • Rahman, N.1
  • 42
    • 84904354146 scopus 로고    scopus 로고
    • The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in Brca1–deficient mice
    • To, C, Kim, EH, Royce, DB, et al. The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in Brca1–deficient mice. Cancer Prev Res (Phila) 7 (2014), 698–707.
    • (2014) Cancer Prev Res (Phila) , vol.7 , pp. 698-707
    • To, C.1    Kim, E.H.2    Royce, D.B.3
  • 43
    • 84964398060 scopus 로고    scopus 로고
    • Microsatellite instability as a biomarker for PD–1 blockade
    • Dudley, JC, Lin, MT, Le, DT, Eshleman, JR, Microsatellite instability as a biomarker for PD–1 blockade. Clin Cancer Res 22 (2016), 813–820.
    • (2016) Clin Cancer Res , vol.22 , pp. 813-820
    • Dudley, J.C.1    Lin, M.T.2    Le, D.T.3    Eshleman, J.R.4
  • 44
    • 84932628341 scopus 로고    scopus 로고
    • PD–1 blockade in tumors with mismatch-repair deficiency
    • Le, DT, Uram, JN, Wang, H, et al. PD–1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372 (2015), 2509–2520.
    • (2015) N Engl J Med , vol.372 , pp. 2509-2520
    • Le, D.T.1    Uram, J.N.2    Wang, H.3
  • 45
    • 84944898663 scopus 로고    scopus 로고
    • A phase 3 randomized trial of nicotinamide for skin–cancer chemoprevention
    • Chen, AC, Martin, AJ, Choy, B, et al. A phase 3 randomized trial of nicotinamide for skin–cancer chemoprevention. N Engl J Med 373 (2015), 1618–1626.
    • (2015) N Engl J Med , vol.373 , pp. 1618-1626
    • Chen, A.C.1    Martin, A.J.2    Choy, B.3
  • 46
    • 84962327352 scopus 로고    scopus 로고
    • Effect of sulindac and erlotinib vs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial
    • Samadder, NJ, Neklason, DW, Boucher, KM, et al. Effect of sulindac and erlotinib vs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial. JAMA 315 (2016), 1266–1275.
    • (2016) JAMA , vol.315 , pp. 1266-1275
    • Samadder, N.J.1    Neklason, D.W.2    Boucher, K.M.3
  • 48
    • 85015636587 scopus 로고    scopus 로고
    • MGUS to myeloma: a mysterious gammopathy of underexplored significance
    • Dhodapkar, MV, MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood 128 (2016), 2599–2606.
    • (2016) Blood , vol.128 , pp. 2599-2606
    • Dhodapkar, M.V.1
  • 49
    • 85018592899 scopus 로고    scopus 로고
    • Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer
    • Pearlman, R, Frankel, WL, Swanson, B, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 3 (2017), 464–471.
    • (2017) JAMA Oncol , vol.3 , pp. 464-471
    • Pearlman, R.1    Frankel, W.L.2    Swanson, B.3
  • 50
    • 84951293785 scopus 로고    scopus 로고
    • Patterns and functional implications of rare germline variants across 12 cancer types
    • Lu, C, Xie, M, Wendl, MC, et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun, 6, 2015, 10086.
    • (2015) Nat Commun , vol.6 , pp. 10086
    • Lu, C.1    Xie, M.2    Wendl, M.C.3
  • 51
    • 84984760593 scopus 로고    scopus 로고
    • Somatic and germline genetics at the JAK2 locus
    • Campbell, PJ, Somatic and germline genetics at the JAK2 locus. Nat Genet 41 (2009), 385–386.
    • (2009) Nat Genet , vol.41 , pp. 385-386
    • Campbell, P.J.1
  • 52
    • 79953302806 scopus 로고    scopus 로고
    • Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions
    • Liu, W, He, L, Ramirez, J, et al. Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions. Cancer Res 71 (2011), 2423–2427.
    • (2011) Cancer Res , vol.71 , pp. 2423-2427
    • Liu, W.1    He, L.2    Ramirez, J.3
  • 53
    • 85016626649 scopus 로고    scopus 로고
    • Cancer susceptibility gene mutations in individuals with colorectal cancer
    • Yurgelun, MB, Kulke, MH, Fuchs, CS, et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 35 (2017), 1086–1095.
    • (2017) J Clin Oncol , vol.35 , pp. 1086-1095
    • Yurgelun, M.B.1    Kulke, M.H.2    Fuchs, C.S.3
  • 54
    • 85012118567 scopus 로고    scopus 로고
    • Translating germline cancer risk into precision prevention
    • Yurgelun, MB, Chenevix-Trench, G, Lippman, SM, Translating germline cancer risk into precision prevention. Cell 168 (2017), 566–570.
    • (2017) Cell , vol.168 , pp. 566-570
    • Yurgelun, M.B.1    Chenevix-Trench, G.2    Lippman, S.M.3
  • 55
    • 84975295506 scopus 로고    scopus 로고
    • RANK ligand as a potential target for breast cancer prevention in BRCA1–mutation carriers
    • Nolan, E, Vaillant, F, Branstetter, D, et al. RANK ligand as a potential target for breast cancer prevention in BRCA1–mutation carriers. Nat Med 22 (2016), 933–939.
    • (2016) Nat Med , vol.22 , pp. 933-939
    • Nolan, E.1    Vaillant, F.2    Branstetter, D.3
  • 56
    • 84971659586 scopus 로고    scopus 로고
    • Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long–term prospective follow-up studies from three European expert centers
    • Vasen, H, Ibrahim, I, Ponce, CG, et al. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long–term prospective follow-up studies from three European expert centers. J Clin Oncol 34 (2016), 2010–2019.
    • (2016) J Clin Oncol , vol.34 , pp. 2010-2019
    • Vasen, H.1    Ibrahim, I.2    Ponce, C.G.3
  • 57
    • 85012982843 scopus 로고    scopus 로고
    • Risk stratification of Barrett's oesophagus using a non–endoscopic sampling method coupled with a biomarker panel: a cohort study
    • Ross-Innes, CS, Chettouh, H, Achilleos, A, et al. Risk stratification of Barrett's oesophagus using a non–endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol 2 (2017), 23–31.
    • (2017) Lancet Gastroenterol Hepatol , vol.2 , pp. 23-31
    • Ross-Innes, C.S.1    Chettouh, H.2    Achilleos, A.3
  • 59
    • 84973164097 scopus 로고    scopus 로고
    • Genomic landscape of colorectal mucosa and adenomas
    • Borras, E, San Lucas, FA, Chang, K, et al. Genomic landscape of colorectal mucosa and adenomas. Cancer Prev Res (Phila) 9 (2016), 417–427.
    • (2016) Cancer Prev Res (Phila) , vol.9 , pp. 417-427
    • Borras, E.1    San Lucas, F.A.2    Chang, K.3
  • 60
    • 85009470013 scopus 로고    scopus 로고
    • Insertions and deletions target lineage-defining genes in human cancers
    • Imielinski, M, Guo, G, Meyerson, M, Insertions and deletions target lineage-defining genes in human cancers. Cell 168 (2017), 460–472.
    • (2017) Cell , vol.168 , pp. 460-472
    • Imielinski, M.1    Guo, G.2    Meyerson, M.3
  • 61
    • 85012921656 scopus 로고    scopus 로고
    • Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia
    • Kotini, AG, Chang, CJ, Chow, A, et al. Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia. Cell Stem Cell 20 (2017), 315–328.
    • (2017) Cell Stem Cell , vol.20 , pp. 315-328
    • Kotini, A.G.1    Chang, C.J.2    Chow, A.3
  • 62
    • 85009113270 scopus 로고    scopus 로고
    • A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation
    • Nestorowa, S, Hamey, FK, Pijuan Sala, B, et al. A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation. Blood 128 (2016), e20–e31.
    • (2016) Blood , vol.128 , pp. e20-e31
    • Nestorowa, S.1    Hamey, F.K.2    Pijuan Sala, B.3
  • 63
    • 84958729616 scopus 로고    scopus 로고
    • A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation
    • Kaufman, CK, Mosimann, C, Fan, ZP, et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science, 351, 2016, aad2197.
    • (2016) Science , vol.351 , pp. aad2197
    • Kaufman, C.K.1    Mosimann, C.2    Fan, Z.P.3
  • 64
    • 85018823113 scopus 로고    scopus 로고
    • Childhood cancers
    • H Gelband P Jha R Sankaranaryanan S Horton 3rd edn. World Bank Washington, DC
    • Gupta, S, Howard, SC, Hunger, SP, et al. Childhood cancers. Gelband, H, Jha, P, Sankaranaryanan, R, Horton, S, (eds.) Disease control priorities, 3rd edn., 2015, World Bank, Washington, DC.
    • (2015) Disease control priorities
    • Gupta, S.1    Howard, S.C.2    Hunger, S.P.3
  • 65
    • 84964004871 scopus 로고    scopus 로고
    • New costly cancer treatments face hurdles getting to patients
    • (accessed May 9, 2017).
    • Plumridge, H, New costly cancer treatments face hurdles getting to patients. Wall Street Journal, Oct 6, 2014 https://www.wsj.com/articles/new-costly-cancer-treatments-face-hurdles-getting-to-patients-1412627150 (accessed May 9, 2017).
    • (2014) Wall Street Journal
    • Plumridge, H.1
  • 66
    • 84916218648 scopus 로고    scopus 로고
    • Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer
    • Yoda, Y, Takeshima, H, Niwa, T, et al. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 18 (2015), 65–76.
    • (2015) Gastric Cancer , vol.18 , pp. 65-76
    • Yoda, Y.1    Takeshima, H.2    Niwa, T.3
  • 67
    • 85011306580 scopus 로고    scopus 로고
    • Not all H3K4 methylations are created equal: Mll2/COMPASS dependency in primordial germ cell specification
    • Hu, D, Gao, X, Cao, K, et al. Not all H3K4 methylations are created equal: Mll2/COMPASS dependency in primordial germ cell specification. Mol Cell 65 (2017), 460–475.
    • (2017) Mol Cell , vol.65 , pp. 460-475
    • Hu, D.1    Gao, X.2    Cao, K.3
  • 68
    • 84983233354 scopus 로고    scopus 로고
    • Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus
    • Martinez, P, Timmer, MR, Lau, CT, et al. Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus. Nat Commun, 7, 2016, 12158.
    • (2016) Nat Commun , vol.7 , pp. 12158
    • Martinez, P.1    Timmer, M.R.2    Lau, C.T.3
  • 69
    • 84863229772 scopus 로고    scopus 로고
    • Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm
    • Hou, Y, Song, L, Zhu, P, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148 (2012), 873–885.
    • (2012) Cell , vol.148 , pp. 873-885
    • Hou, Y.1    Song, L.2    Zhu, P.3
  • 70
    • 85017360311 scopus 로고    scopus 로고
    • Scaling single-cell genomics from phenomenology to mechanism
    • Tanay, A, Regev, A, Scaling single-cell genomics from phenomenology to mechanism. Nature 541 (2017), 331–338.
    • (2017) Nature , vol.541 , pp. 331-338
    • Tanay, A.1    Regev, A.2
  • 71
  • 72
    • 84960799406 scopus 로고    scopus 로고
    • Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening
    • Smith, RA, Andrews, K, Brooks, D, et al. Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 66 (2016), 95–114.
    • (2016) CA Cancer J Clin , vol.66 , pp. 95-114
    • Smith, R.A.1    Andrews, K.2    Brooks, D.3
  • 73
    • 85020082265 scopus 로고    scopus 로고
    • Universal genetic testing for younger patients with colorectal cancer
    • Vilar, E, Stoffel, EM, Universal genetic testing for younger patients with colorectal cancer. JAMA Oncol 3 (2016), 448–449.
    • (2016) JAMA Oncol , vol.3 , pp. 448-449
    • Vilar, E.1    Stoffel, E.M.2
  • 74
    • 70350608273 scopus 로고    scopus 로고
    • A community effort to reduce the black/white breast cancer mortality disparity in Chicago
    • Ansell, D, Grabler, P, Whitman, S, et al. A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Caus Control 20 (2009), 1681–1688.
    • (2009) Cancer Caus Control , vol.20 , pp. 1681-1688
    • Ansell, D.1    Grabler, P.2    Whitman, S.3
  • 75
    • 84866562681 scopus 로고    scopus 로고
    • Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors
    • Grabler, P, Dupuy, D, Rai, J, Bernstein, S, Ansell, D, Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors. Breast Cancer Res Treat 135 (2012), 549–553.
    • (2012) Breast Cancer Res Treat , vol.135 , pp. 549-553
    • Grabler, P.1    Dupuy, D.2    Rai, J.3    Bernstein, S.4    Ansell, D.5
  • 77
    • 70349939381 scopus 로고    scopus 로고
    • decreased incidence of hepatocellular carcinoma in hepatitis b vaccinees: a 20-year follow-up study
    • Chang, M-H, You, S-L, Chen, C-J, et al., the Taiwan Hepatoma Study Group. decreased incidence of hepatocellular carcinoma in hepatitis b vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101 (2009), 1348–1355.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 1348-1355
    • Chang, M.-H.1    You, S.-L.2    Chen, C.-J.3
  • 78
    • 84862750557 scopus 로고    scopus 로고
    • Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement
    • Moyer, VA, Force, USPST, Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 156 (2012), 880–891.
    • (2012) Ann Intern Med , vol.156 , pp. 880-891
    • Moyer, V.A.1    Force, U.2
  • 79
  • 80
    • 84973649618 scopus 로고    scopus 로고
    • Cancer treatment and survivorship statistics, 2016
    • Miller, KD, Siegel, RL, Lin, CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66 (2016), 271–289.
    • (2016) CA Cancer J Clin , vol.66 , pp. 271-289
    • Miller, K.D.1    Siegel, R.L.2    Lin, C.C.3
  • 81
    • 85051765476 scopus 로고    scopus 로고
    • Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008
    • Donin, N, Filson, C, Drakaki, A, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 122 (2016), 3075–3086.
    • (2016) Cancer , vol.122 , pp. 3075-3086
    • Donin, N.1    Filson, C.2    Drakaki, A.3
  • 82
    • 24944584561 scopus 로고    scopus 로고
    • A teachable moment for oncologists: cancer survivors, 10 million strong and growing!
    • Ganz, PA, A teachable moment for oncologists: cancer survivors, 10 million strong and growing!. J Clin Oncol 23 (2005), 5458–5460.
    • (2005) J Clin Oncol , vol.23 , pp. 5458-5460
    • Ganz, P.A.1
  • 85
    • 84880653943 scopus 로고    scopus 로고
    • eliminating racial disparities in colorectal cancer in the real world: it took a village
    • Grubbs, SS, Polite, BN, Carney, J, et al. eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol 31 (2013), 1928–1930.
    • (2013) J Clin Oncol , vol.31 , pp. 1928-1930
    • Grubbs, S.S.1    Polite, B.N.2    Carney, J.3
  • 86
    • 85027437072 scopus 로고    scopus 로고
    • Leveraging implementation science to improve cancer care delivery and patient outcomes
    • Mitchell, SA, Chambers, DA, Leveraging implementation science to improve cancer care delivery and patient outcomes. J Oncol Pract 13 (2017), 523–529.
    • (2017) J Oncol Pract , vol.13 , pp. 523-529
    • Mitchell, S.A.1    Chambers, D.A.2
  • 87
    • 85011955335 scopus 로고    scopus 로고
    • How much longer will we put up with $100,000 cancer drugs?
    • Workman, P, Draetta, GF, Schellens, JH, Bernards, R, How much longer will we put up with $100,000 cancer drugs?. Cell 168 (2017), 579–583.
    • (2017) Cell , vol.168 , pp. 579-583
    • Workman, P.1    Draetta, G.F.2    Schellens, J.H.3    Bernards, R.4
  • 88
    • 85021105020 scopus 로고    scopus 로고
    • Clinical benefit, price and approval characteristics of FDA–approved new drugs for treating advanced solid cancer, 2000–2015
    • Vivot, A, Jacot, J, Zeitoun, JD, Ravaud, P, Crequit, P, Porcher, R, Clinical benefit, price and approval characteristics of FDA–approved new drugs for treating advanced solid cancer, 2000–2015. Ann Oncol 28 (2017), 1111–1116.
    • (2017) Ann Oncol , vol.28 , pp. 1111-1116
    • Vivot, A.1    Jacot, J.2    Zeitoun, J.D.3    Ravaud, P.4    Crequit, P.5    Porcher, R.6
  • 89
    • 84959128138 scopus 로고    scopus 로고
    • Innovation in the pharmaceutical industry: New estimates of R&D costs
    • DiMasi, JA, Grabowski, HG, Hansen, RW, Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ 47 (2016), 20–33.
    • (2016) J Health Econ , vol.47 , pp. 20-33
    • DiMasi, J.A.1    Grabowski, H.G.2    Hansen, R.W.3
  • 90
    • 84892370974 scopus 로고    scopus 로고
    • Biomedical research: increasing value, reducing waste
    • Macleod, MR, Michie, S, Roberts, et al. Biomedical research: increasing value, reducing waste. Lancet 383 (2014), 101–104.
    • (2014) Lancet , vol.383 , pp. 101-104
    • Macleod, M.R.1    Michie, S.2    Roberts3
  • 91
    • 84859169880 scopus 로고    scopus 로고
    • Drug development: raise standards for preclinical cancer research
    • Begley, CG, Ellis, LM, Drug development: raise standards for preclinical cancer research. Nature 483 (2012), 531–533.
    • (2012) Nature , vol.483 , pp. 531-533
    • Begley, C.G.1    Ellis, L.M.2
  • 92
    • 85012110528 scopus 로고    scopus 로고
    • Clonal heterogeneity and tumor evolution: past, present, and the future
    • McGranahan, N, Swanton, C, Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168 (2017), 613–628.
    • (2017) Cell , vol.168 , pp. 613-628
    • McGranahan, N.1    Swanton, C.2
  • 93
    • 84998678876 scopus 로고    scopus 로고
    • Factors associated with failure of oncology drugs in late-stage clinical development: a systematic review
    • Jardim, DL, Groves, ES, Breitfeld, PP, Kurzrock, R, Factors associated with failure of oncology drugs in late-stage clinical development: a systematic review. Cancer Treat Rev 52 (2017), 12–21.
    • (2017) Cancer Treat Rev , vol.52 , pp. 12-21
    • Jardim, D.L.1    Groves, E.S.2    Breitfeld, P.P.3    Kurzrock, R.4
  • 94
    • 85050577464 scopus 로고    scopus 로고
    • Academic drug discovery centers adapt to shifts in funding sources. Universities are pushing their novel molecules into clinical trials
    • Jarvis, LM, Academic drug discovery centers adapt to shifts in funding sources. Universities are pushing their novel molecules into clinical trials. Chemical Engineering News 95 (2017), 16–18.
    • (2017) Chemical Engineering News , vol.95 , pp. 16-18
    • Jarvis, L.M.1
  • 95
    • 0036467826 scopus 로고    scopus 로고
    • Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
    • Vogel, CL, Cobleigh, MA, Tripathy, D, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20 (2002), 719–726.
    • (2002) J Clin Oncol , vol.20 , pp. 719-726
    • Vogel, C.L.1    Cobleigh, M.A.2    Tripathy, D.3
  • 96
    • 55549101623 scopus 로고    scopus 로고
    • DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
    • Ley, TJ, Mardis, ER, Ding, L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456 (2008), 66–72.
    • (2008) Nature , vol.456 , pp. 66-72
    • Ley, T.J.1    Mardis, E.R.2    Ding, L.3
  • 97
    • 84928770388 scopus 로고    scopus 로고
    • Neoantigens in cancer immunotherapy
    • Schumacher, TN, Schreiber, RD, Neoantigens in cancer immunotherapy. Science 348 (2015), 69–74.
    • (2015) Science , vol.348 , pp. 69-74
    • Schumacher, T.N.1    Schreiber, R.D.2
  • 98
    • 84963621254 scopus 로고    scopus 로고
    • Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
    • Topalian, SL, Taube, JM, Anders, RA, Pardoll, DM, Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 16 (2016), 275–287.
    • (2016) Nat Rev Cancer , vol.16 , pp. 275-287
    • Topalian, S.L.1    Taube, J.M.2    Anders, R.A.3    Pardoll, D.M.4
  • 99
    • 84990046448 scopus 로고    scopus 로고
    • Interleukin–10: an immune–activating cytokine in cancer immunotherapy
    • Zhang, H, Wang, Y, Hwang, ES, He, Y-W, Interleukin–10: an immune–activating cytokine in cancer immunotherapy. J CLin Oncol 34 (2016), 3576–3578.
    • (2016) J CLin Oncol , vol.34 , pp. 3576-3578
    • Zhang, H.1    Wang, Y.2    Hwang, E.S.3    He, Y.-W.4
  • 101
    • 84994364943 scopus 로고    scopus 로고
    • Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD–1 blockade
    • Pauken, KE, Sammons, MA, Odorizzi, PM, et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD–1 blockade. Science 354 (2016), 1160–1165.
    • (2016) Science , vol.354 , pp. 1160-1165
    • Pauken, K.E.1    Sammons, M.A.2    Odorizzi, P.M.3
  • 102
    • 84963614956 scopus 로고    scopus 로고
    • Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
    • Tirosh, I, Izar, B, Prakadan, SM, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352 (2016), 189–196.
    • (2016) Science , vol.352 , pp. 189-196
    • Tirosh, I.1    Izar, B.2    Prakadan, S.M.3
  • 103
    • 84929684999 scopus 로고    scopus 로고
    • Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets
    • Macosko, EZ, Basu, A, Satija, R, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161 (2015), 1202–1214.
    • (2015) Cell , vol.161 , pp. 1202-1214
    • Macosko, E.Z.1    Basu, A.2    Satija, R.3
  • 104
    • 84996606989 scopus 로고    scopus 로고
    • Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip
    • Benam, KH, Novak, R, Nawroth, J, et al. Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip. Cell Systems 3 (2016), 456–466.
    • (2016) Cell Systems , vol.3 , pp. 456-466
    • Benam, K.H.1    Novak, R.2    Nawroth, J.3
  • 105
    • 84982175048 scopus 로고    scopus 로고
    • Genomic alteration-driven clinical trial designs in oncology
    • Simon, R, Genomic alteration-driven clinical trial designs in oncology. Ann Intern Med 165 (2016), 270–278.
    • (2016) Ann Intern Med , vol.165 , pp. 270-278
    • Simon, R.1
  • 106
    • 84947286516 scopus 로고    scopus 로고
    • Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility
    • Ignatiadis, M, Lee, M, Jeffrey, SS, Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Clin Cancer Res 21 (2015), 4786–4800.
    • (2015) Clin Cancer Res , vol.21 , pp. 4786-4800
    • Ignatiadis, M.1    Lee, M.2    Jeffrey, S.S.3
  • 107
    • 85016957443 scopus 로고    scopus 로고
    • From trial to target populations—calibrating real-world data
    • Najafzadeh, M, Schneeweiss, S, From trial to target populations—calibrating real-world data. N Engl J Med 376 (2017), 1203–1205.
    • (2017) N Engl J Med , vol.376 , pp. 1203-1205
    • Najafzadeh, M.1    Schneeweiss, S.2
  • 108
    • 85016289170 scopus 로고    scopus 로고
    • Advantages of a truly open-access data-sharing model
    • Bertagnolli, MM, Sartor, O, Chabner, BA, et al. Advantages of a truly open-access data-sharing model. N Engl J Med 376 (2017), 1178–1181.
    • (2017) N Engl J Med , vol.376 , pp. 1178-1181
    • Bertagnolli, M.M.1    Sartor, O.2    Chabner, B.A.3
  • 109
    • 85017428498 scopus 로고    scopus 로고
    • Drug development, trial design, and endpoints in oncology: adapting to rapidly changing science
    • Blumenthal, GM, Goldberg, KB, Pazdur, R, Drug development, trial design, and endpoints in oncology: adapting to rapidly changing science. Clin Pharmacol Ther 101 (2017), 572–574.
    • (2017) Clin Pharmacol Ther , vol.101 , pp. 572-574
    • Blumenthal, G.M.1    Goldberg, K.B.2    Pazdur, R.3
  • 110
    • 85018463691 scopus 로고    scopus 로고
    • Reevaluating eligibility criteria-balancing patient protection and participation in oncology trials
    • Beaver, JA, Ison, G, Pazdur, R, Reevaluating eligibility criteria-balancing patient protection and participation in oncology trials. N Engl J Med 376 (2017), 1504–1505.
    • (2017) N Engl J Med , vol.376 , pp. 1504-1505
    • Beaver, J.A.1    Ison, G.2    Pazdur, R.3
  • 111
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: the next generation
    • Hanahan, D, Weinberg, RA, Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 112
    • 79960915471 scopus 로고    scopus 로고
    • The third revolution: the convergence of the life sciences, physical sciences and engineerinG
    • (accessed Feb 17, 2017).
    • Sharp, PA, Cooney, CL, Kastern, MA, et al. The third revolution: the convergence of the life sciences, physical sciences and engineerinG. http://research.uc.edu/Libraries/Advanced_Seminar_Documents/MIT_White_Paper_on_Convergence_pd.sflb.ashx, 2011 (accessed Feb 17, 2017).
    • (2011)
    • Sharp, P.A.1    Cooney, C.L.2    Kastern, M.A.3
  • 113
    • 84987725265 scopus 로고    scopus 로고
    • A U.S. “Cancer Moonshot” to accelerate cancer research
    • Singer, DS, Jacks, T, Jaffee, E, A U.S. “Cancer Moonshot” to accelerate cancer research. Science 353 (2016), 1105–1106.
    • (2016) Science , vol.353 , pp. 1105-1106
    • Singer, D.S.1    Jacks, T.2    Jaffee, E.3
  • 114
    • 84897143486 scopus 로고    scopus 로고
    • The $1,000 genome
    • Hayden, EC, The $1,000 genome. Nature, 507, 2014, 295.
    • (2014) Nature , vol.507 , pp. 295
    • Hayden, E.C.1
  • 115
    • 85010936415 scopus 로고    scopus 로고
    • DNA sequencing technologies: 2006–2016
    • Mardis, ER, DNA sequencing technologies: 2006–2016. Nat Protoc 12 (2017), 213–218.
    • (2017) Nat Protoc , vol.12 , pp. 213-218
    • Mardis, E.R.1
  • 117
    • 84923106217 scopus 로고    scopus 로고
    • Therapeutic genome editing: prospects and challenges
    • Cox, DBT, Platt, RJ, Zhang, F, Therapeutic genome editing: prospects and challenges. Nat Med 21 (2015), 121–131.
    • (2015) Nat Med , vol.21 , pp. 121-131
    • Cox, D.B.T.1    Platt, R.J.2    Zhang, F.3
  • 118
    • 84959852078 scopus 로고    scopus 로고
    • Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering
    • Kelley, SO, Mirkin, CA, Walt, DR, Ismagilov, RF, Toner, M, Sargent, EH, Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering. Nat Nanotechnol 9 (2014), 969–980.
    • (2014) Nat Nanotechnol , vol.9 , pp. 969-980
    • Kelley, S.O.1    Mirkin, C.A.2    Walt, D.R.3    Ismagilov, R.F.4    Toner, M.5    Sargent, E.H.6
  • 119
    • 85029919483 scopus 로고    scopus 로고
    • Ultrasensitive tumour-penetrating nanosensors of protease activity
    • published online April 10.
    • Kwon, EJ, Dudani, JS, Bhatia, SN, Ultrasensitive tumour-penetrating nanosensors of protease activity. Nat Biomed Eng, 2017 published online April 10. DOI:10.1038/s41551-017-0054.
    • (2017) Nat Biomed Eng
    • Kwon, E.J.1    Dudani, J.S.2    Bhatia, S.N.3
  • 120
    • 84872176550 scopus 로고    scopus 로고
    • Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease
    • Kwong, GA, von Maltzahn, G, Murugappan, G, et al. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol 31 (2013), 63–70.
    • (2013) Nat Biotechnol , vol.31 , pp. 63-70
    • Kwong, G.A.1    von Maltzahn, G.2    Murugappan, G.3
  • 121
    • 84928677711 scopus 로고    scopus 로고
    • An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
    • Jonas, O, Landry, HM, Fuller, JE, et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci Transl Med, 7, 2015, 284ra57.
    • (2015) Sci Transl Med , vol.7 , pp. 284ra57
    • Jonas, O.1    Landry, H.M.2    Fuller, J.E.3
  • 122
    • 84946215806 scopus 로고    scopus 로고
    • Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids
    • Huang, L, Holtzinger, A, Jagan, I, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med 21 (2015), 1364–1371.
    • (2015) Nat Med , vol.21 , pp. 1364-1371
    • Huang, L.1    Holtzinger, A.2    Jagan, I.3
  • 123
    • 84908576857 scopus 로고    scopus 로고
    • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
    • Phillips, E, Penate-Medina, O, Zanzonico, PB, et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med, 6, 2014, 260ra149.
    • (2014) Sci Transl Med , vol.6 , pp. 260ra149
    • Phillips, E.1    Penate-Medina, O.2    Zanzonico, P.B.3
  • 124
    • 85042185090 scopus 로고    scopus 로고
    • Merck and Moderna announce strategic collaboration to advance novel mRNA-based personalized cancer vaccines with KEYTRUDA (pembrolizumab) for the treatment of multiple types of cancer
    • (accessed May 8, 2017).
    • Moderna Therapeutics. Merck and Moderna announce strategic collaboration to advance novel mRNA-based personalized cancer vaccines with KEYTRUDA (pembrolizumab) for the treatment of multiple types of cancer. https://www.modernatx.com/newsroom/press-releases/merck-and-moderna-announce-strategic-collaboration-advance-novel-mrna-based, June 29, 2016 (accessed May 8, 2017).
    • (2016)
  • 125
    • 84877120847 scopus 로고    scopus 로고
    • First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
    • Tabernero, J, Shapiro, GI, LoRusso, PM, et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov 3 (2013), 406–417.
    • (2013) Cancer Discov , vol.3 , pp. 406-417
    • Tabernero, J.1    Shapiro, G.I.2    LoRusso, P.M.3
  • 127
    • 84900563057 scopus 로고    scopus 로고
    • A Nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways
    • Morton, SW, Lee, MJ, Deng, ZJ, et al. A Nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. Sci Signal, 7, 2014, ra44.
    • (2014) Sci Signal , vol.7 , pp. ra44
    • Morton, S.W.1    Lee, M.J.2    Deng, Z.J.3
  • 128
    • 84990855364 scopus 로고    scopus 로고
    • Engineering T cells with customized therapeutic response programs using synthetic notch receptors
    • Roybal, KT, Williams, JZ, Morsut, L, et al. Engineering T cells with customized therapeutic response programs using synthetic notch receptors. Cell 167 (2016), 419–432.
    • (2016) Cell , vol.167 , pp. 419-432
    • Roybal, K.T.1    Williams, J.Z.2    Morsut, L.3
  • 129
    • 85017503720 scopus 로고    scopus 로고
    • In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
    • Smith, TT, Stephan, SB, Moffett, HF, et al. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nat Nanotechnol 12 (2017), 813–820.
    • (2017) Nat Nanotechnol , vol.12 , pp. 813-820
    • Smith, T.T.1    Stephan, S.B.2    Moffett, H.F.3
  • 130
    • 84927130807 scopus 로고    scopus 로고
    • Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
    • Sharma, P, Allison, JP, Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161 (2015), 205–214.
    • (2015) Cell , vol.161 , pp. 205-214
    • Sharma, P.1    Allison, J.P.2
  • 131
    • 84938350452 scopus 로고    scopus 로고
    • Combination cancer immunotherapy and new immunomodulatory targets
    • Mahoney, KM, Rennert, PD, Freeman, GJ, Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14 (2015), 561–584.
    • (2015) Nat Rev Drug Discov , vol.14 , pp. 561-584
    • Mahoney, K.M.1    Rennert, P.D.2    Freeman, G.J.3
  • 132
    • 85006459521 scopus 로고    scopus 로고
    • Combination Approaches with Immune–Checkpoint Blockade in Cancer Therapy
    • Swart, M, Verbrugge, I, Beltman, JB, Combination Approaches with Immune–Checkpoint Blockade in Cancer Therapy. Front Oncol, 6, 2016, 233.
    • (2016) Front Oncol , vol.6 , pp. 233
    • Swart, M.1    Verbrugge, I.2    Beltman, J.B.3
  • 133
    • 84928761118 scopus 로고    scopus 로고
    • Mutational landscape determines sensitivity to PD–1 blockade in non–small cell lung cancer
    • Rizvi, NA, Hellmann, MD, Snyder, A, et al. Mutational landscape determines sensitivity to PD–1 blockade in non–small cell lung cancer. Science 348 (2015), 124–128.
    • (2015) Science , vol.348 , pp. 124-128
    • Rizvi, N.A.1    Hellmann, M.D.2    Snyder, A.3
  • 134
    • 85002396993 scopus 로고    scopus 로고
    • T-cell transfer therapy targeting mutant KRAS in cancer
    • Tran, E, Robbins, PF, Lu, Y-C, et al. T-cell transfer therapy targeting mutant KRAS in cancer. N Engl J Med 375 (2016), 2255–2262.
    • (2016) N Engl J Med , vol.375 , pp. 2255-2262
    • Tran, E.1    Robbins, P.F.2    Lu, Y.-C.3
  • 135
    • 85042194378 scopus 로고    scopus 로고
    • Gut bacteria associated with cancer immunotherapy response in melanoma
    • University of Texas M D Anderson Cancer Center. Gut bacteria associated with cancer immunotherapy response in melanoma. ScienceDaily, Feb 21, 2017.
    • (2017) ScienceDaily
  • 136
    • 85007427057 scopus 로고    scopus 로고
    • Driving gene-engineered T cell immunotherapy of cancer
    • Johnson, LA, June, CH, Driving gene-engineered T cell immunotherapy of cancer. Cell Res 27 (2017), 38–58.
    • (2017) Cell Res , vol.27 , pp. 38-58
    • Johnson, L.A.1    June, C.H.2
  • 137
    • 85007529846 scopus 로고    scopus 로고
    • A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    • Zhang, E, Xu, H, A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. J Hematol Oncol, 10, 2017, 1.
    • (2017) J Hematol Oncol , vol.10 , pp. 1
    • Zhang, E.1    Xu, H.2
  • 138
    • 85018387101 scopus 로고    scopus 로고
    • Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition
    • Ren, J, Liu, X, Fang, C, Jiang, S, June, CH, Zhao, Y, Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin Cancer Res 23 (2016), 2255–2266.
    • (2016) Clin Cancer Res , vol.23 , pp. 2255-2266
    • Ren, J.1    Liu, X.2    Fang, C.3    Jiang, S.4    June, C.H.5    Zhao, Y.6
  • 140
    • 84891018674 scopus 로고    scopus 로고
    • Survivors of childhood and adolescent cancer: life-long risks and responsibilities
    • Robison, LL, Hudson, MM, Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14 (2014), 61–70.
    • (2014) Nat Rev Cancer , vol.14 , pp. 61-70
    • Robison, L.L.1    Hudson, M.M.2
  • 141
    • 84878854824 scopus 로고    scopus 로고
    • Clinical ascertainment of health outcomes among adults treated for childhood cancer
    • Hudson, MM, Ness, KK, Gurney, JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 12 (2013), 2371–2381.
    • (2013) JAMA , vol.12 , pp. 2371-2381
    • Hudson, M.M.1    Ness, K.K.2    Gurney, J.G.3
  • 142
    • 84994517579 scopus 로고    scopus 로고
    • Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study
    • Bhakta, N, Liu, N, Yeo, F, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 17 (2016), 1325–1334.
    • (2016) Lancet Oncol , vol.17 , pp. 1325-1334
    • Bhakta, N.1    Liu, N.2    Yeo, F.3
  • 143
    • 65549140230 scopus 로고    scopus 로고
    • Social outcomes in the Childhood Cancer Survivor Study Cohort
    • Gurney, JG, Krull, KR, Kadan-Lottick, NS, et al. Social outcomes in the Childhood Cancer Survivor Study Cohort. J Clin Oncol 27 (2009), 2390–2395.
    • (2009) J Clin Oncol , vol.27 , pp. 2390-2395
    • Gurney, J.G.1    Krull, K.R.2    Kadan-Lottick, N.S.3
  • 144
    • 77449117312 scopus 로고    scopus 로고
    • Suicidal ideation in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    • Recklitis, CJ, Diller, LR, Li, X, Najita, J, Robison, LL, Zeltzer, LK, Suicidal ideation in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 28 (2010), 655–661.
    • (2010) J Clin Oncol , vol.28 , pp. 655-661
    • Recklitis, C.J.1    Diller, L.R.2    Li, X.3    Najita, J.4    Robison, L.L.5    Zeltzer, L.K.6
  • 145
    • 77951242627 scopus 로고    scopus 로고
    • A model-based estimate of cumulative excess mortality in survivors of childhood cancer
    • Yeh, JM, Nekhlyudov, L, Goldie, SJ, Mertens, AC, Diller, LR, A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med 152 (2010), 409–417.
    • (2010) Ann Intern Med , vol.152 , pp. 409-417
    • Yeh, J.M.1    Nekhlyudov, L.2    Goldie, S.J.3    Mertens, A.C.4    Diller, L.R.5
  • 146
    • 84872773655 scopus 로고    scopus 로고
    • 21st-century hazards of smoking and benefits of cessation in the United States
    • Jha, P, Ramasundarahettige, C, Landsman, V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368 (2013), 341–350.
    • (2013) N Engl J Med , vol.368 , pp. 341-350
    • Jha, P.1    Ramasundarahettige, C.2    Landsman, V.3
  • 147
    • 84959377864 scopus 로고    scopus 로고
    • Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium protocols (2000–2010)
    • Bona, K, Blonquist, TM, Neuberg, DS, Silverman, LB, Wolfe, J, Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium protocols (2000–2010). Pediatr Blood Cancer 63 (2016), 1012–1018.
    • (2016) Pediatr Blood Cancer , vol.63 , pp. 1012-1018
    • Bona, K.1    Blonquist, T.M.2    Neuberg, D.S.3    Silverman, L.B.4    Wolfe, J.5
  • 149
    • 84960422100 scopus 로고    scopus 로고
    • Guideline for the treatment of breakthrough and the prevention of chemotherapy-induced nausea and vomiting in children with cancer
    • Flank, J, Robinson, PD, Holdsworth, M, et al. Guideline for the treatment of breakthrough and the prevention of chemotherapy-induced nausea and vomiting in children with cancer. Pediatr Blood Cancer 63 (2016), 1144–1151.
    • (2016) Pediatr Blood Cancer , vol.63 , pp. 1144-1151
    • Flank, J.1    Robinson, P.D.2    Holdsworth, M.3
  • 150
    • 84896987650 scopus 로고    scopus 로고
    • Prevention and treatment of oral mucositis in children with cancer
    • Miller, MM, Donald, DV, Hagemann, TM, Prevention and treatment of oral mucositis in children with cancer. J Pediatr Pharmacol Ther 17 (2012), 340–350.
    • (2012) J Pediatr Pharmacol Ther , vol.17 , pp. 340-350
    • Miller, M.M.1    Donald, D.V.2    Hagemann, T.M.3
  • 151
    • 84994545580 scopus 로고    scopus 로고
    • Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow–up of a prospective observational study
    • Villani, A, Shore, A, Wasserman, JD, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow–up of a prospective observational study. Lancet Oncol 17 (2016), 1295–1305.
    • (2016) Lancet Oncol , vol.17 , pp. 1295-1305
    • Villani, A.1    Shore, A.2    Wasserman, J.D.3
  • 152
    • 84949449519 scopus 로고    scopus 로고
    • Germline mutations in predisposition genes in pediatric cancer
    • Zhang, J, Walsh, MF, Wu, G, et al. Germline mutations in predisposition genes in pediatric cancer. New Engl J Med 373 (2015), 2336–2346.
    • (2015) New Engl J Med , vol.373 , pp. 2336-2346
    • Zhang, J.1    Walsh, M.F.2    Wu, G.3
  • 153
    • 65549169968 scopus 로고    scopus 로고
    • The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research
    • Robison, LL, Armstrong, GT, Boice, JD, et al. The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27 (2009), 2308–2318.
    • (2009) J Clin Oncol , vol.27 , pp. 2308-2318
    • Robison, L.L.1    Armstrong, G.T.2    Boice, J.D.3
  • 154
    • 85019243142 scopus 로고    scopus 로고
    • Approach for classification and severity–grading of long–term health events among childhood cancer survivors in the St. Jude Lifetime Cohort
    • Hudson, MM, Ehrhardt, MJ, Bhakta, N, et al. Approach for classification and severity–grading of long–term health events among childhood cancer survivors in the St. Jude Lifetime Cohort. Cancer Epidemiol Biomarkers Prev 26 (2016), 666–674.
    • (2016) Cancer Epidemiol Biomarkers Prev , vol.26 , pp. 666-674
    • Hudson, M.M.1    Ehrhardt, M.J.2    Bhakta, N.3
  • 155
    • 34250839958 scopus 로고    scopus 로고
    • Health-status of adult survivors of childhood cancer: A large-scale population-based study from the British childhood cancer survivor study
    • Reulen, RC, Winter, DL, Lancashire, ER, et al. Health-status of adult survivors of childhood cancer: A large-scale population-based study from the British childhood cancer survivor study. Int J Cancer 121 (2007), 633–640.
    • (2007) Int J Cancer , vol.121 , pp. 633-640
    • Reulen, R.C.1    Winter, D.L.2    Lancashire, E.R.3
  • 156
    • 84903604562 scopus 로고    scopus 로고
    • Aging and risk of severe, disabling, life–threatening, and fatal events in the Childhood Cancer Survivor Study
    • Armstrong, GT, Kawashima, T, Leisenring, W, et al. Aging and risk of severe, disabling, life–threatening, and fatal events in the Childhood Cancer Survivor Study. J Clin Oncol 32 (2014), 1218–1227.
    • (2014) J Clin Oncol , vol.32 , pp. 1218-1227
    • Armstrong, G.T.1    Kawashima, T.2    Leisenring, W.3
  • 157
    • 84959532264 scopus 로고    scopus 로고
    • Reduction in late mortality among 5-year survivors of childhood cancer
    • Armstrong, GT, Chen, Y, Yasui, Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374 (2016), 833–842.
    • (2016) N Engl J Med , vol.374 , pp. 833-842
    • Armstrong, G.T.1    Chen, Y.2    Yasui, Y.3
  • 158
    • 70649113052 scopus 로고    scopus 로고
    • Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    • Ross, CJ, Katzov-Eckert, H, Dubé MP, et al. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41 (2009), 1345–1349.
    • (2009) Nat Genet , vol.41 , pp. 1345-1349
    • Ross, C.J.1    Katzov-Eckert, H.2    Dubé, M.P.3
  • 159
    • 84863001655 scopus 로고    scopus 로고
    • Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children
    • Visscher, H, Ross, CJ, Rassekh, SR, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 30 (2012), 1422–1428.
    • (2012) J Clin Oncol , vol.30 , pp. 1422-1428
    • Visscher, H.1    Ross, C.J.2    Rassekh, S.R.3
  • 160
    • 31144442120 scopus 로고    scopus 로고
    • The ‘Lost Tribe’ and the need for a promised land: the challenge of cancer in teenagers and young adults
    • Stevens, MC, The ‘Lost Tribe’ and the need for a promised land: the challenge of cancer in teenagers and young adults. Eur J Cancer 42 (2006), 280–281.
    • (2006) Eur J Cancer , vol.42 , pp. 280-281
    • Stevens, M.C.1
  • 161
    • 65549147127 scopus 로고    scopus 로고
    • Cancer in young adults: 20 to 39 years of age: overview
    • Bleyer, A, Barr, R, Cancer in young adults: 20 to 39 years of age: overview. Semin Oncol 36 (2009), 194–206.
    • (2009) Semin Oncol , vol.36 , pp. 194-206
    • Bleyer, A.1    Barr, R.2
  • 162
    • 35648939837 scopus 로고    scopus 로고
    • Site of oncologic speciatly care for older adolscents in Utah
    • Albritton, KH, Wiggins, CH, Nelson, HE, Weeks, JC, Site of oncologic speciatly care for older adolscents in Utah. J Clin Oncol 25 (2007), 4616–4621.
    • (2007) J Clin Oncol , vol.25 , pp. 4616-4621
    • Albritton, K.H.1    Wiggins, C.H.2    Nelson, H.E.3    Weeks, J.C.4
  • 163
    • 84994037386 scopus 로고    scopus 로고
    • Adoption of pediatric-inspired acute lymphoblastic-leukemia regimens by adult oncologists treating adolescents and young adults: a population-based study
    • Muffly, L, Kichtensztajn, D, Shiraz, P, et al. Adoption of pediatric-inspired acute lymphoblastic-leukemia regimens by adult oncologists treating adolescents and young adults: a population-based study. Cancer 123 (2017), 122–130.
    • (2017) Cancer , vol.123 , pp. 122-130
    • Muffly, L.1    Kichtensztajn, D.2    Shiraz, P.3
  • 164
    • 84963829157 scopus 로고    scopus 로고
    • Accrual of adolescents and young adults with cancer to clinical trials
    • Hay, AE, Rae, C, Fraser, GAM, et al. Accrual of adolescents and young adults with cancer to clinical trials. Curr Oncol 23 (2016), e81–e85.
    • (2016) Curr Oncol , vol.23 , pp. e81-e85
    • Hay, A.E.1    Rae, C.2    Fraser, G.A.M.3
  • 165
    • 84856223787 scopus 로고    scopus 로고
    • Rhabdomyosarcoma in adolescents: a report from teh AIEOP Soft Tissue Sarcoma Committee
    • Bisogno, G, Compostella, A, Ferrari, A, et al. Rhabdomyosarcoma in adolescents: a report from teh AIEOP Soft Tissue Sarcoma Committee. Cancer 118 (2012), 821–827.
    • (2012) Cancer , vol.118 , pp. 821-827
    • Bisogno, G.1    Compostella, A.2    Ferrari, A.3
  • 166
    • 84863923825 scopus 로고    scopus 로고
    • Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non–Hispanic white children with acute lymphoblastic leukemia: a report from the Children's Oncology Group
    • Bhatia, S, Landier, W, Shangguan, M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non–Hispanic white children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Clin Oncol 30 (2012), 2094–2101.
    • (2012) J Clin Oncol , vol.30 , pp. 2094-2101
    • Bhatia, S.1    Landier, W.2    Shangguan, M.3
  • 167
    • 84866884531 scopus 로고    scopus 로고
    • Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits
    • Brasme, JF, Morfouace, M, Grill, J, et al. Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 13 (2012), e445–e459.
    • (2012) Lancet Oncol , vol.13 , pp. e445-e459
    • Brasme, J.F.1    Morfouace, M.2    Grill, J.3
  • 168
    • 84888015278 scopus 로고    scopus 로고
    • Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescents/young adult and younger patients
    • Canner, J, Alonzo, TA, Franklin, J, et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescents/young adult and younger patients. Cancer 119 (2013), 4162–4169.
    • (2013) Cancer , vol.119 , pp. 4162-4169
    • Canner, J.1    Alonzo, T.A.2    Franklin, J.3
  • 169
    • 84924412997 scopus 로고    scopus 로고
    • Long-term outcome of a pediatric inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
    • DeAngelo, DJ, Stevenson, KE, Dalhberg, SE, et al. Long-term outcome of a pediatric inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia 29 (2015), 526–534.
    • (2015) Leukemia , vol.29 , pp. 526-534
    • DeAngelo, D.J.1    Stevenson, K.E.2    Dalhberg, S.E.3
  • 170
    • 84927776117 scopus 로고    scopus 로고
    • Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of US Intergroup Trial C10403
    • Stock, W, Luger, SM, Advani, AS, et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of US Intergroup Trial C10403. Blood, 124, 2014, 796.
    • (2014) Blood , vol.124 , pp. 796
    • Stock, W.1    Luger, S.M.2    Advani, A.S.3
  • 171
    • 84986625687 scopus 로고    scopus 로고
    • Use of appropriate initial treatment among adolescents and young adults with cancer
    • Potosky, AL, Harlan, LC, Albritton, K, et al. Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst, 106, 2014, dju300.
    • (2014) J Natl Cancer Inst , vol.106 , pp. dju300
    • Potosky, A.L.1    Harlan, L.C.2    Albritton, K.3
  • 172
    • 84884517643 scopus 로고    scopus 로고
    • Young adult cancer services in the UK: the journey to a national network
    • Carr, R, Whiteson, M, Edwards, M, Morgan, S, Young adult cancer services in the UK: the journey to a national network. Clin Med 13 (2013), 258–262.
    • (2013) Clin Med , vol.13 , pp. 258-262
    • Carr, R.1    Whiteson, M.2    Edwards, M.3    Morgan, S.4
  • 173
    • 84896308804 scopus 로고    scopus 로고
    • Low socioeconomic status is associated with worse survival in children with cancer: a systematic review
    • Gupta, S, Wilejto, M, Pole, JD, Guttmann, A, Sung, L, Low socioeconomic status is associated with worse survival in children with cancer: a systematic review. PLoS One, 9, 2014, e89482.
    • (2014) PLoS One , vol.9 , pp. e89482
    • Gupta, S.1    Wilejto, M.2    Pole, J.D.3    Guttmann, A.4    Sung, L.5
  • 174
    • 84903278539 scopus 로고    scopus 로고
    • Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries
    • Gupta, S, Rivera-Luna, R, Ribeiro, R, Howard, SC, Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries. PLoS Med, 11, 2014, e1001656.
    • (2014) PLoS Med , vol.11 , pp. e1001656
    • Gupta, S.1    Rivera-Luna, R.2    Ribeiro, R.3    Howard, S.C.4
  • 175
    • 84958093148 scopus 로고    scopus 로고
    • NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
    • Moriyami, T, Nishii, R, Perez-Andreu, V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 48 (2016), 367–373.
    • (2016) Nat Genet , vol.48 , pp. 367-373
    • Moriyami, T.1    Nishii, R.2    Perez-Andreu, V.3
  • 176
    • 75249092032 scopus 로고    scopus 로고
    • Teleoncology: current and future applications for improving cancer care globally
    • Hazin, R, Qaddoumi, I, Teleoncology: current and future applications for improving cancer care globally. Lancet Oncol 11 (2010), 204–210.
    • (2010) Lancet Oncol , vol.11 , pp. 204-210
    • Hazin, R.1    Qaddoumi, I.2
  • 177
    • 84862249169 scopus 로고    scopus 로고
    • Improving the histopathologic diagnosis of pediatric malignancies in a low-resource setting by combining focused training and telepathology strategies
    • Santiago, TC, Jenkins, JJ, Pedrosa, F, et al. Improving the histopathologic diagnosis of pediatric malignancies in a low-resource setting by combining focused training and telepathology strategies. Pediatr Blood Cancer 59 (2012), 221–225.
    • (2012) Pediatr Blood Cancer , vol.59 , pp. 221-225
    • Santiago, T.C.1    Jenkins, J.J.2    Pedrosa, F.3
  • 178
    • 84888802466 scopus 로고    scopus 로고
    • Statistics
    • (accessed Sept 21, 2017).
    • Office of Cancer Survivorship Division of Cancer Control & Population Sciences, National Cancer Institute. Statistics. https://cancercontrol.cancer.gov/ocs/statistics/statistics.html (accessed Sept 21, 2017).
  • 180
    • 79960112592 scopus 로고    scopus 로고
    • Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina
    • Mayer, DK, Travers, D, Wyss, A, Leak, A, Waller, A, Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 29 (2011), 2683–2688.
    • (2011) J Clin Oncol , vol.29 , pp. 2683-2688
    • Mayer, D.K.1    Travers, D.2    Wyss, A.3    Leak, A.4    Waller, A.5
  • 181
    • 82955195816 scopus 로고    scopus 로고
    • Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
    • Nekhlyudov, L, Li, L, Ross-Degnan, D, Wagner, AK, Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat 130 (2011), 681–689.
    • (2011) Breast Cancer Res Treat , vol.130 , pp. 681-689
    • Nekhlyudov, L.1    Li, L.2    Ross-Degnan, D.3    Wagner, A.K.4
  • 182
    • 84874667686 scopus 로고    scopus 로고
    • A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians
    • Huiart, L, Ferdynus, C, Giorgi, R, A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians. Breast Cancer Res Treat 138 (2013), 325–328.
    • (2013) Breast Cancer Res Treat , vol.138 , pp. 325-328
    • Huiart, L.1    Ferdynus, C.2    Giorgi, R.3
  • 183
    • 84929467361 scopus 로고    scopus 로고
    • Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial
    • Bakitas, MA, Tosteson, TD, Li, Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33 (2015), 1438–1445.
    • (2015) J Clin Oncol , vol.33 , pp. 1438-1445
    • Bakitas, M.A.1    Tosteson, T.D.2    Li, Z.3
  • 184
    • 79960577663 scopus 로고    scopus 로고
    • A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer
    • Gilbertson-White, S, Aouizerat, BE, Jahan, T, Miaskowski, C, A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliat Support Care 9 (2011), 81–102.
    • (2011) Palliat Support Care , vol.9 , pp. 81-102
    • Gilbertson-White, S.1    Aouizerat, B.E.2    Jahan, T.3    Miaskowski, C.4
  • 185
    • 77955877759 scopus 로고    scopus 로고
    • Early palliative care for patients with metastatic non–small–cell lung cancer
    • Temel, JS, Greer, JA, Muzikansky, A, et al. Early palliative care for patients with metastatic non–small–cell lung cancer. N Engl J Med 363 (2010), 733–742.
    • (2010) N Engl J Med , vol.363 , pp. 733-742
    • Temel, J.S.1    Greer, J.A.2    Muzikansky, A.3
  • 186
    • 68949090752 scopus 로고    scopus 로고
    • Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial
    • Bakitas, M, Lyons, KD, Hegel, MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302 (2009), 741–749.
    • (2009) JAMA , vol.302 , pp. 741-749
    • Bakitas, M.1    Lyons, K.D.2    Hegel, M.T.3
  • 187
    • 85009923590 scopus 로고    scopus 로고
    • Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update
    • Ferrell, BR, Temel, JS, Temin, S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35 (2017), 96–112.
    • (2017) J Clin Oncol , vol.35 , pp. 96-112
    • Ferrell, B.R.1    Temel, J.S.2    Temin, S.3
  • 188
    • 85020425017 scopus 로고    scopus 로고
    • Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    • Basch, E, Deal, AM, Dueck, AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318 (2017), 197–198.
    • (2017) JAMA , vol.318 , pp. 197-198
    • Basch, E.1    Deal, A.M.2    Dueck, A.C.3
  • 189
    • 78149250018 scopus 로고    scopus 로고
    • Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors
    • Ingle, JN, Schaid, DJ, Goss, PE, et al. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol 28 (2010), 4674–4682.
    • (2010) J Clin Oncol , vol.28 , pp. 4674-4682
    • Ingle, J.N.1    Schaid, D.J.2    Goss, P.E.3
  • 190
    • 84934324585 scopus 로고    scopus 로고
    • Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
    • Boora, GK, Kulkarni, AA, Kanwar, R, et al. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). J Neurol Sci 357 (2015), 35–40.
    • (2015) J Neurol Sci , vol.357 , pp. 35-40
    • Boora, G.K.1    Kulkarni, A.A.2    Kanwar, R.3
  • 191
    • 84981765193 scopus 로고    scopus 로고
    • Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
    • Boora, GK, Kanwar, R, Kulkarni, AA, et al. Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance). Cancer Med 5 (2016), 631–639.
    • (2016) Cancer Med , vol.5 , pp. 631-639
    • Boora, G.K.1    Kanwar, R.2    Kulkarni, A.A.3
  • 192
    • 84962167822 scopus 로고    scopus 로고
    • Scrambler Therapy for the management of chronic pain
    • Majithia, N, Smith, TJ, Coyne, PJ, et al. Scrambler Therapy for the management of chronic pain. Support Care Cancer 24 (2016), 2807–2814.
    • (2016) Support Care Cancer , vol.24 , pp. 2807-2814
    • Majithia, N.1    Smith, T.J.2    Coyne, P.J.3
  • 193
    • 85009286571 scopus 로고    scopus 로고
    • Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
    • Astrup, GL, Hofsø K, Bjordal, K, et al. Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence. Acta Oncol 56 (2017), 462–470.
    • (2017) Acta Oncol , vol.56 , pp. 462-470
    • Astrup, G.L.1    Hofsø, K.2    Bjordal, K.3
  • 194
    • 34249089533 scopus 로고    scopus 로고
    • Symptom control trials: a 20–year experience
    • Loprinzi, CL, Barton, DL, Jatoi, A, et al. Symptom control trials: a 20–year experience. J Support Oncol 5 (2007), 119–128.
    • (2007) J Support Oncol , vol.5 , pp. 119-128
    • Loprinzi, C.L.1    Barton, D.L.2    Jatoi, A.3
  • 195
    • 0025302267 scopus 로고
    • Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
    • Loprinzi, CL, Ellison, NM, Schaid, DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82 (1990), 1127–1132.
    • (1990) J Natl Cancer Inst , vol.82 , pp. 1127-1132
    • Loprinzi, C.L.1    Ellison, N.M.2    Schaid, D.J.3
  • 196
    • 0033521964 scopus 로고    scopus 로고
    • Lack of effect of coumarin in women with lymphedema after treatment for breast cancer
    • Loprinzi, CL, Kugler, JW, Sloan, JA, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340 (1999), 346–350.
    • (1999) N Engl J Med , vol.340 , pp. 346-350
    • Loprinzi, C.L.1    Kugler, J.W.2    Sloan, J.A.3
  • 197
    • 0028085970 scopus 로고
    • Megestrol acetate for the prevention of hot flashes
    • Loprinzi, CL, Michalak, JC, Quella, SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331 (1994), 347–352.
    • (1994) N Engl J Med , vol.331 , pp. 347-352
    • Loprinzi, C.L.1    Michalak, J.C.2    Quella, S.K.3
  • 198
    • 34249713221 scopus 로고    scopus 로고
    • Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3
    • Barton, DL, Wender, DB, Sloan, JA, et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 99 (2007), 672–679.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 672-679
    • Barton, D.L.1    Wender, D.B.2    Sloan, J.A.3
  • 199
    • 0036299151 scopus 로고    scopus 로고
    • Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
    • Hammack, JE, Michalak, JC, Loprinzi, CL, et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98 (2002), 195–203.
    • (2002) Pain , vol.98 , pp. 195-203
    • Hammack, J.E.1    Michalak, J.C.2    Loprinzi, C.L.3
  • 200
    • 85014016250 scopus 로고    scopus 로고
    • Perceived cognitive function for breast cancer survivors: association of genetic and behaviourally related variables for inflammation
    • Myers, JS, Koleck, TA, Sereika, SM, Conley, YP, Bender, CM, Perceived cognitive function for breast cancer survivors: association of genetic and behaviourally related variables for inflammation. Support Care Cancer 25 (2017), 2475–2484.
    • (2017) Support Care Cancer , vol.25 , pp. 2475-2484
    • Myers, J.S.1    Koleck, T.A.2    Sereika, S.M.3    Conley, Y.P.4    Bender, C.M.5
  • 201
    • 84937520484 scopus 로고    scopus 로고
    • Patterns of change in cognitive function with anastrozole therapy
    • Bender, CM, Merriman, JD, Gentry, AL, et al. Patterns of change in cognitive function with anastrozole therapy. Cancer 121 (2015), 2627–2636.
    • (2015) Cancer , vol.121 , pp. 2627-2636
    • Bender, C.M.1    Merriman, J.D.2    Gentry, A.L.3
  • 202
    • 84953634860 scopus 로고    scopus 로고
    • Cancer-related fatigue and associated disability in post-treatment cancer survivors
    • Jones, JM, Olson, K, Catton, P, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv 10 (2016), 51–61.
    • (2016) J Cancer Surviv , vol.10 , pp. 51-61
    • Jones, J.M.1    Olson, K.2    Catton, P.3
  • 203
    • 84981238908 scopus 로고    scopus 로고
    • Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
    • Bao, T, Basal, C, Seluzicki, C, Li, SQ, Seidman, AD, Mao, JJ, Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159 (2016), 327–333.
    • (2016) Breast Cancer Res Treat , vol.159 , pp. 327-333
    • Bao, T.1    Basal, C.2    Seluzicki, C.3    Li, S.Q.4    Seidman, A.D.5    Mao, J.J.6
  • 204
    • 84978062965 scopus 로고    scopus 로고
    • The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling
    • Kolb, NA, Smith, AG, Singleton, JR, et al. The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol 73 (2016), 860–866.
    • (2016) JAMA Neurol , vol.73 , pp. 860-866
    • Kolb, N.A.1    Smith, A.G.2    Singleton, J.R.3
  • 206
    • 84973281958 scopus 로고    scopus 로고
    • Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    • Gulati, G, Heck, SL, Ree, AH, et al. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J 37 (2016), 1671–1680.
    • (2016) Eur Heart J , vol.37 , pp. 1671-1680
    • Gulati, G.1    Heck, S.L.2    Ree, A.H.3
  • 207
    • 84923269274 scopus 로고    scopus 로고
    • Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia
    • Diouf, B, Crews, KR, Lew, G, et al. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 313 (2015), 815–823.
    • (2015) JAMA , vol.313 , pp. 815-823
    • Diouf, B.1    Crews, K.R.2    Lew, G.3
  • 208
    • 84883172515 scopus 로고    scopus 로고
    • Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
    • Leandro-Garcia, LJ, Inglada-Perez, L, Pita, G, et al. Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. J Med Genet 50 (2013), 599–605.
    • (2013) J Med Genet , vol.50 , pp. 599-605
    • Leandro-Garcia, L.J.1    Inglada-Perez, L.2    Pita, G.3
  • 209
    • 85008643932 scopus 로고    scopus 로고
    • Emotional distress impacts quality of life evaluation: a report from the Childhood Cancer Survivor Study
    • Huang, IC, Brinkman, TM, Armstrong, GT, Leisenring, W, Robison, LL, Krull, KR, Emotional distress impacts quality of life evaluation: a report from the Childhood Cancer Survivor Study. J Cancer Surviv 11 (2017), 309–319.
    • (2017) J Cancer Surviv , vol.11 , pp. 309-319
    • Huang, I.C.1    Brinkman, T.M.2    Armstrong, G.T.3    Leisenring, W.4    Robison, L.L.5    Krull, K.R.6
  • 210
    • 84874109218 scopus 로고    scopus 로고
    • Does fear of cancer recurrence predict cancer survivors' health care use?
    • Lebel, S, Tomei, C, Feldstain, A, Beattie, S, McCallum, M, Does fear of cancer recurrence predict cancer survivors' health care use?. Support Care Cancer 21 (2013), 901–906.
    • (2013) Support Care Cancer , vol.21 , pp. 901-906
    • Lebel, S.1    Tomei, C.2    Feldstain, A.3    Beattie, S.4    McCallum, M.5
  • 212
    • 78649933024 scopus 로고    scopus 로고
    • Estimate of current hospice and palliative medicine physician workforce shortage
    • Lupu, D, American Academy of Hospice and Palliative Medicine Workforce Task Force. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage 40 (2010), 899–911.
    • (2010) J Pain Symptom Manage , vol.40 , pp. 899-911
    • Lupu, D.1
  • 214
    • 84859350578 scopus 로고    scopus 로고
    • Developing the science of end-of-life and palliative care research: National Institute of Nursing Research summit
    • Csikai, EL, Developing the science of end-of-life and palliative care research: National Institute of Nursing Research summit. J Soc Work End Life Palliat Care 7 (2011), 291–299.
    • (2011) J Soc Work End Life Palliat Care , vol.7 , pp. 291-299
    • Csikai, E.L.1
  • 215
    • 84976631469 scopus 로고    scopus 로고
    • The spectrum of caregiving in palliative care for serious, advanced, rare diseases: key issues and research directions
    • Adams, LS, Miller, JL, Grady, PA, The spectrum of caregiving in palliative care for serious, advanced, rare diseases: key issues and research directions. J Palliat Med 19 (2016), 698–705.
    • (2016) J Palliat Med , vol.19 , pp. 698-705
    • Adams, L.S.1    Miller, J.L.2    Grady, P.A.3
  • 216
    • 84895905278 scopus 로고    scopus 로고
    • End-of-life care—what do cancer patients want?
    • Khan, SA, Gomes, B, Higginson, IJ, End-of-life care—what do cancer patients want?. Nat Rev Clin Oncol 11 (2014), 100–108.
    • (2014) Nat Rev Clin Oncol , vol.11 , pp. 100-108
    • Khan, S.A.1    Gomes, B.2    Higginson, I.J.3
  • 217
    • 84986321970 scopus 로고    scopus 로고
    • Using routine data to improve palliative and end of life care
    • Davies, JM, Gao, W, Sleeman, KE, Using routine data to improve palliative and end of life care. BMJ Support Palliat Care 6 (2016), 257–262.
    • (2016) BMJ Support Palliat Care , vol.6 , pp. 257-262
    • Davies, J.M.1    Gao, W.2    Sleeman, K.E.3
  • 218
    • 83555172634 scopus 로고    scopus 로고
    • A pan-European survey of research in end-of-life cancer care
    • Sigurdardottir, KR, Haugen, DF, Bausewein, C, et al., Project PRISMA. A pan-European survey of research in end-of-life cancer care. Support Care Cancer 20 (2012), 39–48.
    • (2012) Support Care Cancer , vol.20 , pp. 39-48
    • Sigurdardottir, K.R.1    Haugen, D.F.2    Bausewein, C.3
  • 219
    • 85021843310 scopus 로고    scopus 로고
    • Foundation funding for palliative and end-of-life care
    • Prina, LL, Foundation funding for palliative and end-of-life care. Health Aff (Millwood) 36 (2017), 1340–1342.
    • (2017) Health Aff (Millwood) , vol.36 , pp. 1340-1342
    • Prina, L.L.1
  • 221
    • 79959961573 scopus 로고    scopus 로고
    • The role of local therapy in the management of lung and liver oligometastases
    • Lo, SS, Moffatt-Bruce, SD, Dawson, LA, et al. The role of local therapy in the management of lung and liver oligometastases. Nature Rev Clin Oncol 8 (2011), 405–416.
    • (2011) Nature Rev Clin Oncol , vol.8 , pp. 405-416
    • Lo, S.S.1    Moffatt-Bruce, S.D.2    Dawson, L.A.3
  • 222
    • 63749100778 scopus 로고    scopus 로고
    • Multi–institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    • Rusthoven, KE, Kavanagh, BD, Cardenes, H, et al. Multi–institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27 (2009), 1572–1578.
    • (2009) J Clin Oncol , vol.27 , pp. 1572-1578
    • Rusthoven, K.E.1    Kavanagh, B.D.2    Cardenes, H.3
  • 223
    • 63749100778 scopus 로고    scopus 로고
    • Multi–institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
    • Rusthoven, KE, Kavanagh, BD, Burri, SH, et al. Multi–institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27 (2009), 1579–1584.
    • (2009) J Clin Oncol , vol.27 , pp. 1579-1584
    • Rusthoven, K.E.1    Kavanagh, B.D.2    Burri, S.H.3
  • 224
    • 3242734176 scopus 로고    scopus 로고
    • Phase I clinical evaluation of near-simultaneous computed tomographic image–guided stereotactic body radiotherapy for spinal metastases
    • Chang, EL, Shiu, AS, Lii, MF, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image–guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 59 (2004), 1288–1294.
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 1288-1294
    • Chang, E.L.1    Shiu, A.S.2    Lii, M.F.3
  • 225
    • 84862827663 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial
    • Wang, XS, Rhines, LD, Shiu, AS, et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial. Lancet Oncol 13 (2012), 395–402.
    • (2012) Lancet Oncol , vol.13 , pp. 395-402
    • Wang, X.S.1    Rhines, L.D.2    Shiu, A.S.3
  • 226
    • 84896699065 scopus 로고    scopus 로고
    • RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1–3) spine metastases: phase 2 results
    • Ryu, S, Pugh, SL, Gerszten, PC, et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1–3) spine metastases: phase 2 results. Pract Radiat Oncol 4 (2014), 76–81.
    • (2014) Pract Radiat Oncol , vol.4 , pp. 76-81
    • Ryu, S.1    Pugh, S.L.2    Gerszten, P.C.3
  • 227
    • 84912066879 scopus 로고    scopus 로고
    • Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer
    • Iyengar, P, Kavanagh, BD, Wardak, Z, et al. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol 32 (2014), 3824–3830.
    • (2014) J Clin Oncol , vol.32 , pp. 3824-3830
    • Iyengar, P.1    Kavanagh, B.D.2    Wardak, Z.3
  • 228
    • 85002622789 scopus 로고    scopus 로고
    • Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first–line systemic therapy: a multicentre, randomised, controlled, phase 2 study
    • Gomez, DR, Blumenschein, GR, Lee, JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first–line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncology 17 (2016), 1672–1682.
    • (2016) Lancet Oncology , vol.17 , pp. 1672-1682
    • Gomez, D.R.1    Blumenschein, G.R.2    Lee, J.J.3
  • 229
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous–cell carcinoma of the head and neck
    • Bonner, JA, Harari, PM, Giralt, J, et al. Radiotherapy plus cetuximab for squamous–cell carcinoma of the head and neck. N Engl J Med 354 (2006), 567–578.
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 230
    • 84961992269 scopus 로고    scopus 로고
    • STAT1 induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy in HNC patients
    • Srivastava, RM, Trivedi, S, Concha-Benavente, F, et al. STAT1 induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy in HNC patients. Cancer Immunol Res 3 (2015), 936–945.
    • (2015) Cancer Immunol Res , vol.3 , pp. 936-945
    • Srivastava, R.M.1    Trivedi, S.2    Concha-Benavente, F.3
  • 231
    • 84907010373 scopus 로고    scopus 로고
    • Interaction of radiation therapy with molecular targeted agents
    • Morris, ZS, Harari, PM, Interaction of radiation therapy with molecular targeted agents. J Clin Oncol 32 (2014), 2886–2893.
    • (2014) J Clin Oncol , vol.32 , pp. 2886-2893
    • Morris, Z.S.1    Harari, P.M.2
  • 232
    • 84959148338 scopus 로고    scopus 로고
    • Science in focus: combining radiotherapy with inhibitors of the DNA damage response
    • Chalmers, AJ, Science in focus: combining radiotherapy with inhibitors of the DNA damage response. Clin Oncol (R Coll Radiol) 5 (2016), 279–282.
    • (2016) Clin Oncol (R Coll Radiol) , vol.5 , pp. 279-282
    • Chalmers, A.J.1
  • 233
    • 84857815877 scopus 로고    scopus 로고
    • Immunologic correlates of the abscopal effect in a patient with melanoma
    • Postow, MA, Callahan, MK, Barker, CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366 (2012), 925–931.
    • (2012) N Engl J Med , vol.366 , pp. 925-931
    • Postow, M.A.1    Callahan, M.K.2    Barker, C.A.3
  • 234
    • 84861398744 scopus 로고    scopus 로고
    • Abscopal effect in a patient with melanoma
    • Hiniker, SM, Chen, DS, Knox, SJ, Abscopal effect in a patient with melanoma. N Engl J Med, 366, 2012, 2035.
    • (2012) N Engl J Med , vol.366 , pp. 2035
    • Hiniker, S.M.1    Chen, D.S.2    Knox, S.J.3
  • 235
    • 84872202826 scopus 로고    scopus 로고
    • The abscopal effect associated with a systemic antimelanoma immune response
    • Stamell, EF, Wolchok, JD, Gnjatic, S, et al. The abscopal effect associated with a systemic antimelanoma immune response. Int J Radiat Oncol Biol Phys 85 (2013), 293–295.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , pp. 293-295
    • Stamell, E.F.1    Wolchok, J.D.2    Gnjatic, S.3
  • 236
    • 84862124594 scopus 로고    scopus 로고
    • Phase 1 study of stereotactic body radiotherapy and interleukin–2: tumor and immunological responses
    • Seung, SK, Curti, BD, Crittenden, M, et al. Phase 1 study of stereotactic body radiotherapy and interleukin–2: tumor and immunological responses. Sci Transl Med, 4, 2012, 137ra74.
    • (2012) Sci Transl Med , vol.4 , pp. 137ra74
    • Seung, S.K.1    Curti, B.D.2    Crittenden, M.3
  • 237
    • 84875039618 scopus 로고    scopus 로고
    • Combining radiotherapy and cancer immunotherapy: a paradigm shift
    • Formenti, SC, Demaria, S, Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 105 (2013), 256–265.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 256-265
    • Formenti, S.C.1    Demaria, S.2
  • 238
    • 45449090985 scopus 로고    scopus 로고
    • Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity
    • Lugade, AA, Sorensen, EW, Gerber, SA, et al. Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity. J Immunol 180 (2008), 3132–3139.
    • (2008) J Immunol , vol.180 , pp. 3132-3139
    • Lugade, A.A.1    Sorensen, E.W.2    Gerber, S.A.3
  • 239
    • 51549088023 scopus 로고    scopus 로고
    • Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
    • Matsumura, S, Wang, B, Kawashima, N, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 181 (2008), 3099–3107.
    • (2008) J Immunol , vol.181 , pp. 3099-3107
    • Matsumura, S.1    Wang, B.2    Kawashima, N.3
  • 240
    • 0037942745 scopus 로고    scopus 로고
    • Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy
    • Chakraborty, M, Abrams, SI, Camphausen, K, et al. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 170 (2003), 6338–6347.
    • (2003) J Immunol , vol.170 , pp. 6338-6347
    • Chakraborty, M.1    Abrams, S.I.2    Camphausen, K.3
  • 241
    • 84857542033 scopus 로고    scopus 로고
    • Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways
    • Ifeadi, V, Garnett–Benson, C, Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways. PLoS One, 7, 2012, e31762.
    • (2012) PLoS One , vol.7 , pp. e31762
    • Ifeadi, V.1    Garnett-Benson, C.2
  • 242
    • 7444258053 scopus 로고    scopus 로고
    • Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
    • Garnett, CT, Palena, C, Chakarborty, M, Tsang, KY, Schlom, J, Hodge, JW, Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64 (2004), 7985–7994.
    • (2004) Cancer Res , vol.64 , pp. 7985-7994
    • Garnett, C.T.1    Palena, C.2    Chakarborty, M.3    Tsang, K.Y.4    Schlom, J.5    Hodge, J.W.6
  • 243
    • 33646704729 scopus 로고    scopus 로고
    • Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
    • Reits, EA, Hodge, JW, Herberts, CA, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203 (2006), 1259–1271.
    • (2006) J Exp Med , vol.203 , pp. 1259-1271
    • Reits, E.A.1    Hodge, J.W.2    Herberts, C.A.3
  • 244
    • 0034103794 scopus 로고    scopus 로고
    • γ-ray irradiation induces B7. 1 expression in myeloid leukaemic cells
    • Vereecque, R, Buffenoir, G, Gonzalez, R, et al. γ-ray irradiation induces B7. 1 expression in myeloid leukaemic cells. Br J Haematol 108 (2000), 825–831.
    • (2000) Br J Haematol , vol.108 , pp. 825-831
    • Vereecque, R.1    Buffenoir, G.2    Gonzalez, R.3
  • 245
    • 24144443517 scopus 로고    scopus 로고
    • The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
    • Gasser, S, Orsulic, S, Brown, EJ, Raulet, DH, The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005), 1186–1190.
    • (2005) Nature , vol.436 , pp. 1186-1190
    • Gasser, S.1    Orsulic, S.2    Brown, E.J.3    Raulet, D.H.4
  • 246
    • 33750725084 scopus 로고    scopus 로고
    • Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation
    • Kim, J, Son, Y, Park, S, et al. Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med, 38, 2006, 474.
    • (2006) Exp Mol Med , vol.38 , pp. 474
    • Kim, J.1    Son, Y.2    Park, S.3
  • 247
    • 84929366910 scopus 로고    scopus 로고
    • TGFβ is a master regulator of radiation therapy-induced antitumor immunity
    • Vanpouille-Box, C, Diamond, JM, Pilones, KA, et al. TGFβ is a master regulator of radiation therapy-induced antitumor immunity. Cancer Res 75 (2015), 2232–2242.
    • (2015) Cancer Res , vol.75 , pp. 2232-2242
    • Vanpouille-Box, C.1    Diamond, J.M.2    Pilones, K.A.3
  • 248
    • 34247844643 scopus 로고    scopus 로고
    • Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth
    • Tsai, CS, Chen, FH, Wang, CC, et al. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int J Radiat Oncol Biol Phys 68 (2007), 499–507.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 499-507
    • Tsai, C.S.1    Chen, F.H.2    Wang, C.C.3
  • 249
    • 84875024405 scopus 로고    scopus 로고
    • Irradiation promotes an m2 macrophage phenotype in tumor hypoxia
    • Chiang, CS, Fu, SY, Wang, SC, et al. Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Front Oncol, 2, 2012, 89.
    • (2012) Front Oncol , vol.2 , pp. 89
    • Chiang, C.S.1    Fu, S.Y.2    Wang, S.C.3
  • 250
    • 84908691423 scopus 로고    scopus 로고
    • Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response
    • Kuo, P, Bratman, SV, Shultz, DB, et al. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clin Cancer Res 20 (2014), 5558–5569.
    • (2014) Clin Cancer Res , vol.20 , pp. 5558-5569
    • Kuo, P.1    Bratman, S.V.2    Shultz, D.B.3
  • 251
    • 84893876109 scopus 로고    scopus 로고
    • Irradiation and anti–PD–L1 treatment synergistically promote antitumor immunity in mice
    • Deng, L, Liang, H, Burnette, B, et al. Irradiation and anti–PD–L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 124 (2014), 687–695.
    • (2014) J Clin Invest , vol.124 , pp. 687-695
    • Deng, L.1    Liang, H.2    Burnette, B.3
  • 252
    • 0034305965 scopus 로고    scopus 로고
    • Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
    • Brizel, DM, Wasserman, TH, Henke, M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000), 3339–3345.
    • (2000) J Clin Oncol , vol.18 , pp. 3339-3345
    • Brizel, D.M.1    Wasserman, T.H.2    Henke, M.3
  • 253
    • 84901227921 scopus 로고    scopus 로고
    • PHD inhibition mitigates and protects against radiation–induced gastrointestinal toxicity via HIF2
    • Taniguchi, CM, Miao, YR, Diep, AN, et al. PHD inhibition mitigates and protects against radiation–induced gastrointestinal toxicity via HIF2. Sci Transl Med, 6, 2014, 236ra64.
    • (2014) Sci Transl Med , vol.6 , pp. 236ra64
    • Taniguchi, C.M.1    Miao, Y.R.2    Diep, A.N.3
  • 254
    • 84902485527 scopus 로고    scopus 로고
    • Stem cell therapies for the treatment of radiation–induced normal tissue side effects
    • Benderitter, M, Caviggioli, F, Chapel, A, et al. Stem cell therapies for the treatment of radiation–induced normal tissue side effects. Antioxid Redox Signal 21 (2014), 338–355.
    • (2014) Antioxid Redox Signal , vol.21 , pp. 338-355
    • Benderitter, M.1    Caviggioli, F.2    Chapel, A.3
  • 255
    • 84904061727 scopus 로고    scopus 로고
    • Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA
    • Haber, DA, Velculescu, VE, Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov 4 (2014), 650–661.
    • (2014) Cancer Discov , vol.4 , pp. 650-661
    • Haber, D.A.1    Velculescu, V.E.2
  • 256
    • 84941551429 scopus 로고    scopus 로고
    • Predicting radiotherapy responses and treatment outcomes through analysis of circulating tumor DNA
    • Chaudhuri, AA, Binkley, MS, Osmundson, EC, Alizadeh, AA, Diehn, M, Predicting radiotherapy responses and treatment outcomes through analysis of circulating tumor DNA. Semin Radiat Oncol 25 (2015), 305–312.
    • (2015) Semin Radiat Oncol , vol.25 , pp. 305-312
    • Chaudhuri, A.A.1    Binkley, M.S.2    Osmundson, E.C.3    Alizadeh, A.A.4    Diehn, M.5
  • 257
    • 84877099043 scopus 로고    scopus 로고
    • An international collaboration to harmonize the quantitative plasma Epstein–Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
    • Le, QT, Zhang, Q, Cao, H, et al. An international collaboration to harmonize the quantitative plasma Epstein–Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma. Clin Cancer Res 19 (2013), 2208–2215.
    • (2013) Clin Cancer Res , vol.19 , pp. 2208-2215
    • Le, Q.T.1    Zhang, Q.2    Cao, H.3
  • 258
    • 84903218109 scopus 로고    scopus 로고
    • An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
    • Newman, AM, Bratman, SV, To, J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Med 20 (2014), 548–554.
    • (2014) Nature Med , vol.20 , pp. 548-554
    • Newman, A.M.1    Bratman, S.V.2    To, J.3
  • 259
    • 85009404026 scopus 로고    scopus 로고
    • Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
    • Jeong, Y, Hoang, NT, Lovejoy, A, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discov 7 (2017), 86–101.
    • (2017) Cancer Discov , vol.7 , pp. 86-101
    • Jeong, Y.1    Hoang, N.T.2    Lovejoy, A.3
  • 260
    • 85008193431 scopus 로고    scopus 로고
    • A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort–based study
    • Scott, JG, Berglund, A, Schell, MJ, et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort–based study. Lancet Oncol 18 (2016), 202–211.
    • (2016) Lancet Oncol , vol.18 , pp. 202-211
    • Scott, J.G.1    Berglund, A.2    Schell, M.J.3
  • 261
    • 84925348152 scopus 로고    scopus 로고
    • Lung texture in serial thoracic computed tomography scans: correlation of radiomics–based features with radiation therapy dose and radiation pneumonitis development
    • Cunliffe, A, Armato, SG, Castillo, R, et al. Lung texture in serial thoracic computed tomography scans: correlation of radiomics–based features with radiation therapy dose and radiation pneumonitis development. Int J Radiat Oncol Biol Phys 91 (2015), 1048–1056.
    • (2015) Int J Radiat Oncol Biol Phys , vol.91 , pp. 1048-1056
    • Cunliffe, A.1    Armato, S.G.2    Castillo, R.3
  • 262
    • 84898665704 scopus 로고    scopus 로고
    • Comparison of 4–dimensional computed tomography ventilation with nuclear medicine ventilation–perfusion imaging: a clinical validation study
    • Vinogradskiy, Y, Koo, PJ, Castillo, R, et al. Comparison of 4–dimensional computed tomography ventilation with nuclear medicine ventilation–perfusion imaging: a clinical validation study. Int J Radiat Oncol Biol Phys 89 (2014), 199–205.
    • (2014) Int J Radiat Oncol Biol Phys , vol.89 , pp. 199-205
    • Vinogradskiy, Y.1    Koo, P.J.2    Castillo, R.3
  • 263
    • 84975297433 scopus 로고    scopus 로고
    • Regional lung function profiles of stage I and III lung cancer patients: an evaluation for functional avoidance radiation therapy
    • Vinogradskiy, Y, Schubert, L, Diot, Q, et al. Regional lung function profiles of stage I and III lung cancer patients: an evaluation for functional avoidance radiation therapy. Int J Radiat Oncol Biol Phys 95 (2016), 1273–1280.
    • (2016) Int J Radiat Oncol Biol Phys , vol.95 , pp. 1273-1280
    • Vinogradskiy, Y.1    Schubert, L.2    Diot, Q.3
  • 264
    • 84889884752 scopus 로고    scopus 로고
    • Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma
    • Mailhot Vega, RB, Kim, J, Bussière, M, et al. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer 119 (2013), 4299–4307.
    • (2013) Cancer , vol.119 , pp. 4299-4307
    • Mailhot Vega, R.B.1    Kim, J.2    Bussière, M.3
  • 265
    • 84960495145 scopus 로고    scopus 로고
    • Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study
    • Yock, TI, Yeap, BY, Ebb, DH, et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 17 (2016), 287–298.
    • (2016) Lancet Oncol , vol.17 , pp. 287-298
    • Yock, T.I.1    Yeap, B.Y.2    Ebb, D.H.3
  • 266
    • 84951850596 scopus 로고    scopus 로고
    • Clinical outcomes among children with standard–risk medulloblastoma treated with proton and photon radiation therapy: a comparison of disease control and overall survival
    • Eaton, BR, Esiashvili, N, Kim, S, et al. Clinical outcomes among children with standard–risk medulloblastoma treated with proton and photon radiation therapy: a comparison of disease control and overall survival. Int J Radiat Oncol Biol Phys 94 (2016), 133–138.
    • (2016) Int J Radiat Oncol Biol Phys , vol.94 , pp. 133-138
    • Eaton, B.R.1    Esiashvili, N.2    Kim, S.3
  • 267
    • 69249223061 scopus 로고    scopus 로고
    • On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams
    • Andreo, P, On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams. Phys Med Biol, 54, 2009, N205.
    • (2009) Phys Med Biol , vol.54 , pp. N205
    • Andreo, P.1
  • 268
    • 85027976702 scopus 로고    scopus 로고
    • Humbling advances in technology: protons, brainstem necrosis, and the self-driving car
    • MacDonald, SM, Laack, NN, Terezakis, S, Humbling advances in technology: protons, brainstem necrosis, and the self-driving car. Int J Radiat Oncol Biol Phys, 97, 2017, 216.
    • (2017) Int J Radiat Oncol Biol Phys , vol.97 , pp. 216
    • MacDonald, S.M.1    Laack, N.N.2    Terezakis, S.3
  • 269
    • 84907010602 scopus 로고    scopus 로고
    • Promise and pitfalls of heavy-particle therapy
    • Mitin, T, Zietman, AL, Promise and pitfalls of heavy-particle therapy. J Clin Oncol 32 (2014), 2855–2863.
    • (2014) J Clin Oncol , vol.32 , pp. 2855-2863
    • Mitin, T.1    Zietman, A.L.2
  • 270
    • 84982816401 scopus 로고    scopus 로고
    • Carbon ion irradiation withstands cancer stem cells' migration/invasion process in head and neck squamous cell carcinoma (HNSCC)
    • Moncharmont, C, Guy, JB, Wozny, AS, et al. Carbon ion irradiation withstands cancer stem cells' migration/invasion process in head and neck squamous cell carcinoma (HNSCC). Oncotarget, 7, 2016, 47738.
    • (2016) Oncotarget , vol.7 , pp. 47738
    • Moncharmont, C.1    Guy, J.B.2    Wozny, A.S.3
  • 271
    • 84880428467 scopus 로고    scopus 로고
    • Alpha emitter radium-223 and survival in metastatic prostate cancer
    • Parker, C, Nilsson, S, Heinrich, D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 369 (2013), 213–223.
    • (2013) N Engl J Med , vol.369 , pp. 213-223
    • Parker, C.1    Nilsson, S.2    Heinrich, D.3
  • 275
    • 28144449723 scopus 로고    scopus 로고
    • The progress and promise of molecular imaging probes in oncologic drug development
    • Kelloff, GJ, Krohn, KA, Larson, SM, et al. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res 11 (2005), 7967–7985.
    • (2005) Clin Cancer Res , vol.11 , pp. 7967-7985
    • Kelloff, G.J.1    Krohn, K.A.2    Larson, S.M.3
  • 277
    • 85020104379 scopus 로고    scopus 로고
    • Making molecular imaging a clinical tool for precision oncology: a review
    • Mankoff, DA, Farwell, MD, Clark, AS, Pryma, DA, Making molecular imaging a clinical tool for precision oncology: a review. JAMA Oncol 3 (2016), 695–701.
    • (2016) JAMA Oncol , vol.3 , pp. 695-701
    • Mankoff, D.A.1    Farwell, M.D.2    Clark, A.S.3    Pryma, D.A.4
  • 278
    • 77951474500 scopus 로고    scopus 로고
    • 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer
    • 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther 87 (2010), 586–592.
    • (2010) Clin Pharmacol Ther , vol.87 , pp. 586-592
    • Dijkers, E.C.1    Oude Munnink, T.H.2    Kosterink, J.G.3
  • 279
    • 40449093680 scopus 로고    scopus 로고
    • Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol
    • Peterson, LM, Mankoff, DA, Lawton, T, et al. Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol. J Nucl Med 49 (2008), 367–374.
    • (2008) J Nucl Med , vol.49 , pp. 367-374
    • Peterson, L.M.1    Mankoff, D.A.2    Lawton, T.3
  • 281
    • 33745545477 scopus 로고    scopus 로고
    • Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
    • Linden, HM, Stekhova, SA, Link, JM, et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 24 (2006), 2793–2799.
    • (2006) J Clin Oncol , vol.24 , pp. 2793-2799
    • Linden, H.M.1    Stekhova, S.A.2    Link, J.M.3
  • 283
    • 84890308316 scopus 로고    scopus 로고
    • 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO
    • 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. J Nucl Med 54 (2013), 1862–1868.
    • (2013) J Nucl Med , vol.54 , pp. 1862-1868
    • Gebhart, G.1    Gamez, C.2    Holmes, E.3
  • 284
    • 84879919355 scopus 로고    scopus 로고
    • 18F-FDG PET in Hodgkin lymphoma: would PET–adapted clinical trials lead to a paradigm shift?
    • 18F-FDG PET in Hodgkin lymphoma: would PET–adapted clinical trials lead to a paradigm shift?. J Nucl Med 54 (2013), 1082–1093.
    • (2013) J Nucl Med , vol.54 , pp. 1082-1093
    • Kostakoglu, L.1    Gallamini, A.2
  • 286
    • 33745955010 scopus 로고    scopus 로고
    • Positron emission tomography as an imaging biomarker
    • Weber, WA, Positron emission tomography as an imaging biomarker. J Clin Oncol 24 (2006), 3282–3292.
    • (2006) J Clin Oncol , vol.24 , pp. 3282-3292
    • Weber, W.A.1
  • 287
    • 84055222053 scopus 로고    scopus 로고
    • [18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel
    • Contractor, KB, Kenny, LM, Stebbing, J, et al. [18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel. Clin Cancer Res 17 (2011), 7664–7672.
    • (2011) Clin Cancer Res , vol.17 , pp. 7664-7672
    • Contractor, K.B.1    Kenny, L.M.2    Stebbing, J.3
  • 288
    • 58149337441 scopus 로고    scopus 로고
    • 18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung
    • 18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung. Clin Cancer Res 14 (2008), 7423–7429.
    • (2008) Clin Cancer Res , vol.14 , pp. 7423-7429
    • Sohn, H.J.1    Yang, Y.J.2    Ryu, J.S.3
  • 289
    • 84964617575 scopus 로고    scopus 로고
    • Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
    • Gebhart, G, Lamberts, LE, Wimana, Z, et al. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. Ann Oncol 27 (2016), 619–624.
    • (2016) Ann Oncol , vol.27 , pp. 619-624
    • Gebhart, G.1    Lamberts, L.E.2    Wimana, Z.3
  • 291
    • 84946573144 scopus 로고    scopus 로고
    • A phase ii study of 3'–Deoxy–3'–18F–fluorothymidine PET in the assessment of early response of breast cancer to neoadjuvant chemotherapy: results from ACRIN 6688
    • Kostakoglu, L, Duan, F, Idowu, MO, et al. A phase ii study of 3'–Deoxy–3'–18F–fluorothymidine PET in the assessment of early response of breast cancer to neoadjuvant chemotherapy: results from ACRIN 6688. J Nucl Med 56 (2015), 1681–1689.
    • (2015) J Nucl Med , vol.56 , pp. 1681-1689
    • Kostakoglu, L.1    Duan, F.2    Idowu, M.O.3
  • 292
    • 84940449844 scopus 로고    scopus 로고
    • Imaging innate immune responses at tumour initiation: new insights from fish and flies
    • Feng, Y, Martin, P, Imaging innate immune responses at tumour initiation: new insights from fish and flies. Nat Rev Cancer 15 (2015), 556–562.
    • (2015) Nat Rev Cancer , vol.15 , pp. 556-562
    • Feng, Y.1    Martin, P.2
  • 293
    • 84869380716 scopus 로고    scopus 로고
    • Immunology beats cancer: a blueprint for successful translation
    • Pardoll, DM, Immunology beats cancer: a blueprint for successful translation. Nat Immunol 13 (2012), 1129–1132.
    • (2012) Nat Immunol , vol.13 , pp. 1129-1132
    • Pardoll, D.M.1
  • 294
    • 84881084626 scopus 로고    scopus 로고
    • Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
    • Gilles, R, de Geus–Oei, LF, Mulders, PF, Oyen, WJ, Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma. World J Urol 31 (2013), 841–846.
    • (2013) World J Urol , vol.31 , pp. 841-846
    • Gilles, R.1    de Geus–Oei, L.F.2    Mulders, P.F.3    Oyen, W.J.4
  • 295
    • 44849103991 scopus 로고    scopus 로고
    • PET imaging of cancer immunotherapy
    • Tumeh, PC, Radu, CG, Ribas, A, PET imaging of cancer immunotherapy. J Nucl Med 49 (2008), 865–868.
    • (2008) J Nucl Med , vol.49 , pp. 865-868
    • Tumeh, P.C.1    Radu, C.G.2    Ribas, A.3
  • 296
    • 85014322386 scopus 로고    scopus 로고
    • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
    • Seymour, L, Bogaerts, J, Perrone, A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18 (2017), e143–e152.
    • (2017) Lancet Oncol , vol.18 , pp. e143-e152
    • Seymour, L.1    Bogaerts, J.2    Perrone, A.3
  • 297
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors
    • Wahl, RL, Jacene, H, Kasamon, Y, Lodge, MA, From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50:suppl 1 (2009), 122S–150S.
    • (2009) J Nucl Med , vol.50 , pp. 122S-150S
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 298
    • 84928917822 scopus 로고    scopus 로고
    • Pooled Analysis of Long–Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    • Schadendorf, D, Hodi, FS, Robert, C, Weber, JS, Margolin, K, Hamid, O, et al. Pooled Analysis of Long–Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. J Clin Oncol 33 (2015), 1889–1894.
    • (2015) J Clin Oncol , vol.33 , pp. 1889-1894
    • Schadendorf, D.1    Hodi, F.S.2    Robert, C.3    Weber, J.S.4    Margolin, K.5    Hamid, O.6
  • 299
    • 85009383088 scopus 로고    scopus 로고
    • Rapid PD–L1 detection in tumors with PET using a highly specific peptide
    • Chatterjee, S, Lesniak, WG, Miller, MS, et al. Rapid PD–L1 detection in tumors with PET using a highly specific peptide. Biochem Biophys Res Commun 483 (2017), 258–263.
    • (2017) Biochem Biophys Res Commun , vol.483 , pp. 258-263
    • Chatterjee, S.1    Lesniak, W.G.2    Miller, M.S.3
  • 300
    • 84898973055 scopus 로고    scopus 로고
    • Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
    • Topalian, SL, Sznol, M, McDermott, DF, et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol 32 (2014), 1020–1030.
    • (2014) J Clin Oncol , vol.32 , pp. 1020-1030
    • Topalian, S.L.1    Sznol, M.2    McDermott, D.F.3
  • 301
    • 85016924502 scopus 로고    scopus 로고
    • The FDA, Juno Therapeutics, and the ethical imperative of transparency
    • Hey, SP, Kesselheim, AS, The FDA, Juno Therapeutics, and the ethical imperative of transparency. BMJ, 354, 2016, i4435.
    • (2016) BMJ , vol.354 , pp. i4435
    • Hey, S.P.1    Kesselheim, A.S.2
  • 303
    • 84991372950 scopus 로고    scopus 로고
    • Molecular imaging of immunotherapy targets in cancer
    • Ehlerding, EB, England, CG, McNeel, DG, Cai, W, Molecular imaging of immunotherapy targets in cancer. J Nucl Med 57 (2016), 1487–1492.
    • (2016) J Nucl Med , vol.57 , pp. 1487-1492
    • Ehlerding, E.B.1    England, C.G.2    McNeel, D.G.3    Cai, W.4
  • 304
    • 0037022647 scopus 로고    scopus 로고
    • Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography
    • Adonai, N, Nguyen, KN, Walsh, J, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 99 (2002), 3030–3035.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 3030-3035
    • Adonai, N.1    Nguyen, K.N.2    Walsh, J.3
  • 305
    • 33646058046 scopus 로고    scopus 로고
    • Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography
    • Su, H, Chang, DS, Gambhir, SS, Braun, J, Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol 176 (2006), 4459–4467.
    • (2006) J Immunol , vol.176 , pp. 4459-4467
    • Su, H.1    Chang, D.S.2    Gambhir, S.S.3    Braun, J.4
  • 306
    • 84973125305 scopus 로고    scopus 로고
    • Imaging of sleeping beauty–modified CD19–specific T cells Expressing HSV1–thymidine kinase by positron emission tomography
    • Najjar, AM, Manuri, PR, Olivares, S, et al. Imaging of sleeping beauty–modified CD19–specific T cells Expressing HSV1–thymidine kinase by positron emission tomography. Mol Imaging Biol 18 (2016), 838–848.
    • (2016) Mol Imaging Biol , vol.18 , pp. 838-848
    • Najjar, A.M.1    Manuri, P.R.2    Olivares, S.3
  • 307
    • 84929323415 scopus 로고    scopus 로고
    • Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes
    • Lee, HW, Yoon, SY, Singh, TD, et al. Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes. Sci Rep, 5, 2015, 9865.
    • (2015) Sci Rep , vol.5 , pp. 9865
    • Lee, H.W.1    Yoon, S.Y.2    Singh, T.D.3
  • 308
    • 85010451084 scopus 로고    scopus 로고
    • Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
    • Keu, KV, Witney, TH, Yaghoubi, S, et al. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med, 9, 2017, eaag2196.
    • (2017) Sci Transl Med , vol.9 , pp. eaag2196
    • Keu, K.V.1    Witney, T.H.2    Yaghoubi, S.3
  • 309
    • 84961666341 scopus 로고    scopus 로고
    • A humanized antibody for imaging immune checkpoint ligand PD–L1 expression in tumors
    • Chatterjee, S, Lesniak, WG, Gabrielson, M, et al. A humanized antibody for imaging immune checkpoint ligand PD–L1 expression in tumors. Oncotarget 7 (2016), 10215–10227.
    • (2016) Oncotarget , vol.7 , pp. 10215-10227
    • Chatterjee, S.1    Lesniak, W.G.2    Gabrielson, M.3
  • 310
    • 84945555686 scopus 로고    scopus 로고
    • Novel radiotracer for immunoPET imaging of PD–1 checkpoint expression on tumor infiltrating lymphocytes
    • Natarajan, A, Mayer, AT, Xu, L, Reeves, RE, Gano, J, Gambhir, SS, Novel radiotracer for immunoPET imaging of PD–1 checkpoint expression on tumor infiltrating lymphocytes. Bioconjug Chem 26 (2015), 2062–2069.
    • (2015) Bioconjug Chem , vol.26 , pp. 2062-2069
    • Natarajan, A.1    Mayer, A.T.2    Xu, L.3    Reeves, R.E.4    Gano, J.5    Gambhir, S.S.6
  • 312
    • 84978654959 scopus 로고    scopus 로고
    • Immuno–PET imaging of engineered human T cells in tumors
    • Mall, S, Yusufi, N, Wagner, R, et al. Immuno–PET imaging of engineered human T cells in tumors. Cancer Res 76 (2016), 4113–4123.
    • (2016) Cancer Res , vol.76 , pp. 4113-4123
    • Mall, S.1    Yusufi, N.2    Wagner, R.3
  • 313
    • 84963631929 scopus 로고    scopus 로고
    • [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
    • Kim, W, Le, TM, Wei, L, et al. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Proc Natl Acad Sci USA 113 (2016), 4027–4032.
    • (2016) Proc Natl Acad Sci USA , vol.113 , pp. 4027-4032
    • Kim, W.1    Le, T.M.2    Wei, L.3
  • 314
    • 84864545273 scopus 로고    scopus 로고
    • Theranostics: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy—the Bad Berka Experience
    • Baum, RP, Kulkarni, HR, Theranostics: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy—the Bad Berka Experience. Theranostics 2 (2012), 437–447.
    • (2012) Theranostics , vol.2 , pp. 437-447
    • Baum, R.P.1    Kulkarni, H.R.2
  • 315
    • 4644241347 scopus 로고    scopus 로고
    • Diagnostics + therapy=theranostics
    • Warner, S, Diagnostics + therapy=theranostics. The Scientist, Aug 30, 2004.
    • (2004) The Scientist
    • Warner, S.1
  • 316
    • 84954239466 scopus 로고    scopus 로고
    • PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status theranostics
    • Lütje, S, Heskamp, S, Cornelissen, AS, et al. PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status theranostics. Theranostics 5 (2015), 1388–1401.
    • (2015) Theranostics , vol.5 , pp. 1388-1401
    • Lütje, S.1    Heskamp, S.2    Cornelissen, A.S.3
  • 317
    • 80054821668 scopus 로고    scopus 로고
    • Theranostics: combining imaging and therapy
    • Kelkar, SS, Reineke, TM, Theranostics: combining imaging and therapy. Bioconj Chem 22 (2011), 1879–1903.
    • (2011) Bioconj Chem , vol.22 , pp. 1879-1903
    • Kelkar, S.S.1    Reineke, T.M.2
  • 318
    • 84874029226 scopus 로고    scopus 로고
    • From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy
    • Alberti, C, From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy. Eur Rev Med Pharmacol Sci 16 (2012), 1925–1933.
    • (2012) Eur Rev Med Pharmacol Sci , vol.16 , pp. 1925-1933
    • Alberti, C.1
  • 319
    • 84994852273 scopus 로고    scopus 로고
    • K. P. Nuclear medicine in cancer theranostics: beyond the target
    • Taieb, D, Hicks, RJ, K. P. Nuclear medicine in cancer theranostics: beyond the target. J Nucl Med 57 (2016), 1659–1660.
    • (2016) J Nucl Med , vol.57 , pp. 1659-1660
    • Taieb, D.1    Hicks, R.J.2
  • 321
    • 84863460418 scopus 로고    scopus 로고
    • Dose escalation study of no–carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial
    • Matthay, KK, Weiss, B, Villablanca, JG, et al. Dose escalation study of no–carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial. J Nucl Med 53 (2012), 1155–1163.
    • (2012) J Nucl Med , vol.53 , pp. 1155-1163
    • Matthay, K.K.1    Weiss, B.2    Villablanca, J.G.3
  • 322
    • 52449111580 scopus 로고    scopus 로고
    • Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with (90)Y-DOTATOC and (177)Lu-DOTATATE: the role of associated risk factors
    • Bodei, L, Cremonesi, M, Ferrari, M, et al. Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with (90)Y-DOTATOC and (177)Lu-DOTATATE: the role of associated risk factors. Eur J Nucl Med Mol Imaging 35 (2008), 1847–1856.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , pp. 1847-1856
    • Bodei, L.1    Cremonesi, M.2    Ferrari, M.3
  • 323
    • 0034662510 scopus 로고    scopus 로고
    • Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience
    • Kaminski, MS, Estes, J, Zasadny, KR, et al. Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood 96 (2000), 1259–1266.
    • (2000) Blood , vol.96 , pp. 1259-1266
    • Kaminski, M.S.1    Estes, J.2    Zasadny, K.R.3
  • 324
    • 84859316607 scopus 로고    scopus 로고
    • Radioiodine: the classic theranostic agent
    • Silberstein, EB, Radioiodine: the classic theranostic agent. Semin Nucl Med 42 (2012), 164–170.
    • (2012) Semin Nucl Med , vol.42 , pp. 164-170
    • Silberstein, E.B.1
  • 325
    • 84973334406 scopus 로고    scopus 로고
    • Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer
    • Ahn, B-C, Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer. Biomed Res Int 1680464 (2016), 1–9.
    • (2016) Biomed Res Int , vol.1680464 , pp. 1-9
    • Ahn, B.-C.1
  • 326
    • 84859306773 scopus 로고    scopus 로고
    • Theranostics: evolution of the radiopharmaceutical meta–iodobenzylguanidine in endocrine tumors
    • Sisson, JC, Yanik, GA, Theranostics: evolution of the radiopharmaceutical meta–iodobenzylguanidine in endocrine tumors. Semin Nucl Med 42 (2012), 171–184.
    • (2012) Semin Nucl Med , vol.42 , pp. 171-184
    • Sisson, J.C.1    Yanik, G.A.2
  • 327
    • 84991320867 scopus 로고    scopus 로고
    • PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka Experience since 2013
    • Kulkarni, HR, Singh, A, Schuchardt, C, et al. PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka Experience since 2013. J Nucl Med 57 (2016), 97S–104S.
    • (2016) J Nucl Med , vol.57 , pp. 97S-104S
    • Kulkarni, H.R.1    Singh, A.2    Schuchardt, C.3
  • 328
    • 84958630177 scopus 로고    scopus 로고
    • 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease
    • 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease. J Nucl Med 57 (2016), 248–251.
    • (2016) J Nucl Med , vol.57 , pp. 248-251
    • Hermann, K.1    Schottelius, M.2    Lapa, C.3
  • 329
    • 85011961288 scopus 로고    scopus 로고
    • 177Lu–NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use in oncology
    • 177Lu–NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use in oncology. J Nucl Med 58 (2017), 293–299.
    • (2017) J Nucl Med , vol.58 , pp. 293-299
    • Dalm, S.U.1    Bakker, I.L.2    de Blois, E.3
  • 330
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
    • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69 (2001), 89–95.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 89-95
  • 331
    • 79955010368 scopus 로고    scopus 로고
    • Early diagnosis of ovarian carcinoma: is a solution in sight?
    • Lutz, AM, Willmann, JK, Drescher, CW, et al. Early diagnosis of ovarian carcinoma: is a solution in sight?. Radiology 259 (2011), 329–345.
    • (2011) Radiology , vol.259 , pp. 329-345
    • Lutz, A.M.1    Willmann, J.K.2    Drescher, C.W.3
  • 332
    • 84905814502 scopus 로고    scopus 로고
    • Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer
    • Carlsson, A, Nair, VS, Luttgen, MS, et al. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. J Thorac Oncol 9 (2014), 1111–1119.
    • (2014) J Thorac Oncol , vol.9 , pp. 1111-1119
    • Carlsson, A.1    Nair, V.S.2    Luttgen, M.S.3
  • 333
    • 84879834620 scopus 로고    scopus 로고
    • An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer
    • Nair, VS, Keu, KV, Luttgen, MS, et al. An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One, 8, 2013, e67733.
    • (2013) PLoS One , vol.8 , pp. e67733
    • Nair, V.S.1    Keu, K.V.2    Luttgen, M.S.3
  • 334
    • 77956194618 scopus 로고    scopus 로고
    • 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
    • De Giorgi, U, Mego, M, Rohren, EM, et al. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer. J Nucl Med 51 (2010), 1213–1218.
    • (2010) J Nucl Med , vol.51 , pp. 1213-1218
    • De Giorgi, U.1    Mego, M.2    Rohren, E.M.3
  • 335
    • 70249150745 scopus 로고    scopus 로고
    • Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer
    • De Giorgi, U, Valero, V, Rohren, E, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol 27 (2009), 3303–3311.
    • (2009) J Clin Oncol , vol.27 , pp. 3303-3311
    • De Giorgi, U.1    Valero, V.2    Rohren, E.3
  • 336
    • 77949311998 scopus 로고    scopus 로고
    • Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer
    • De Giorgi, U, Valero, V, Rohren, E, et al. Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer. Ann Oncol 21 (2010), 33–39.
    • (2010) Ann Oncol , vol.21 , pp. 33-39
    • De Giorgi, U.1    Valero, V.2    Rohren, E.3
  • 338
    • 84897958983 scopus 로고    scopus 로고
    • Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
    • Fahey, F, Zukotynski, K, Capala, J, Knight, N, Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med 55 (2014), 337–348.
    • (2014) J Nucl Med , vol.55 , pp. 337-348
    • Fahey, F.1    Zukotynski, K.2    Capala, J.3    Knight, N.4
  • 339
    • 84936772103 scopus 로고    scopus 로고
    • Proceedings of the Second NCI–SNMMI workshop on targeted radionuclide therapy
    • Fahey, F, Zukotynski, K, Jadvar, H, Capala, J, Proceedings of the Second NCI–SNMMI workshop on targeted radionuclide therapy. J Nucl Med 56 (2015), 1119–1129.
    • (2015) J Nucl Med , vol.56 , pp. 1119-1129
    • Fahey, F.1    Zukotynski, K.2    Jadvar, H.3    Capala, J.4
  • 340
    • 84930373084 scopus 로고    scopus 로고
    • Summary of the UPICT protocol for 18F–FDG PET/CT imaging in oncology clinical trials
    • Graham, MM, Wahl, RL, Hoffman, JM, et al. Summary of the UPICT protocol for 18F–FDG PET/CT imaging in oncology clinical trials. J Nucl Med 56 (2015), 955–961.
    • (2015) J Nucl Med , vol.56 , pp. 955-961
    • Graham, M.M.1    Wahl, R.L.2    Hoffman, J.M.3
  • 341
    • 85042182900 scopus 로고    scopus 로고
    • Report of the Cancer Moonshot Task Force: executive summary
    • (accessed Oct 1, 2016).
    • Report of the Cancer Moonshot Task Force: executive summary. https://medium.com/cancer-moonshot/report-of-the-cancer-moonshot-task-force-executive-summary-e711f1845ec (accessed Oct 1, 2016).
  • 342
    • 77953632852 scopus 로고    scopus 로고
    • Surgical management and outcomes of colorectal cancer liver metastases
    • Morris, EJ, Forman, D, Thomas, JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97 (2010), 1110–1118.
    • (2010) Br J Surg , vol.97 , pp. 1110-1118
    • Morris, E.J.1    Forman, D.2    Thomas, J.D.3
  • 345
    • 84942586191 scopus 로고    scopus 로고
    • Global cancer surgery: delivering safe, affordable, and timely cancer surgery
    • Sullivan, R, Alatise, OI, Anderson, BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol 16 (2015), 1193–1224.
    • (2015) Lancet Oncol , vol.16 , pp. 1193-1224
    • Sullivan, R.1    Alatise, O.I.2    Anderson, B.O.3
  • 346
    • 73249130298 scopus 로고    scopus 로고
    • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
    • Folprecht, G, Gruenberger, T, Bechstein, WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11 (2010), 38–47.
    • (2010) Lancet Oncol , vol.11 , pp. 38-47
    • Folprecht, G.1    Gruenberger, T.2    Bechstein, W.O.3
  • 347
    • 84989883694 scopus 로고    scopus 로고
    • FOLFIRI plus cetuximab in patients with liver–limited or non–liver–limited RAS wild–type metastatic colorectal cancer: a retrospective subgroup analysis of the CRYSTAL study
    • Köhne, CH, Poston, G, Folprecht, G, et al. FOLFIRI plus cetuximab in patients with liver–limited or non–liver–limited RAS wild–type metastatic colorectal cancer: a retrospective subgroup analysis of the CRYSTAL study. Eur J Surg Oncol 42 (2016), 1540–1547.
    • (2016) Eur J Surg Oncol , vol.42 , pp. 1540-1547
    • Köhne, C.H.1    Poston, G.2    Folprecht, G.3
  • 349
    • 84929868382 scopus 로고    scopus 로고
    • Big data and biomedical informatics: a challenging opportunity
    • Bellazzi, R, Big data and biomedical informatics: a challenging opportunity. Yearb Med Inform 9 (2014), 8–13.
    • (2014) Yearb Med Inform , vol.9 , pp. 8-13
    • Bellazzi, R.1
  • 350
    • 85013080239 scopus 로고    scopus 로고
    • Big data analytics for genomic medicine
    • He, KY, Ge, D, He, MM, Big data analytics for genomic medicine. Int J Mol Sci, 18, 2017, 412.
    • (2017) Int J Mol Sci , vol.18 , pp. 412
    • He, K.Y.1    Ge, D.2    He, M.M.3
  • 352
    • 85013875756 scopus 로고    scopus 로고
    • Sharing big biomedical data
    • Toga, AW, Dinov, D, Sharing big biomedical data. J Big Data, 2, 2015, 7.
    • (2015) J Big Data , vol.2 , pp. 7
    • Toga, A.W.1    Dinov, D.2
  • 353
    • 78649359388 scopus 로고    scopus 로고
    • Big data: community cleverness required
    • Nature. Big data: community cleverness required. Nature, 455, 2008, 1.
    • (2008) Nature , vol.455 , pp. 1
  • 354
    • 84969976828 scopus 로고    scopus 로고
    • On big-data analytics in biomedical research
    • Chow, SC, Kong, Y, On big-data analytics in biomedical research. J Biomed Biostat, 6, 2015, 236.
    • (2015) J Biomed Biostat , vol.6 , pp. 236
    • Chow, S.C.1    Kong, Y.2
  • 355
    • 85099688310 scopus 로고    scopus 로고
    • Making big data useful for health care: a summary of the inaugural MIT Critical Data Conference
    • Badawi, O, Brennan, T, Celi, LA, et al. Making big data useful for health care: a summary of the inaugural MIT Critical Data Conference. JMIR Med Inform, 2, 2014, 2.
    • (2014) JMIR Med Inform , vol.2 , pp. 2
    • Badawi, O.1    Brennan, T.2    Celi, L.A.3
  • 357
    • 85042179068 scopus 로고    scopus 로고
    • NIH launches a united ecosystem for big data. 12 big data to knowledge centers of excellence funded
    • (accessed May 9, 2017).
    • Miller, K, NIH launches a united ecosystem for big data. 12 big data to knowledge centers of excellence funded. http://biomedicalcomputationreview.org/content/nih-launches-united-ecosystem-big-data, Jan 8, 2015 (accessed May 9, 2017).
    • (2015)
    • Miller, K.1
  • 358
    • 84886907976 scopus 로고    scopus 로고
    • Increasing access to the results of federally funded scientific research (memo)
    • (accessed May 9, 2017).
    • Executive Office of the President, Office of Science and Technology Policy. Increasing access to the results of federally funded scientific research (memo). https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/ostp_public_access_memo_2013.pdf, Feb 22, 2013 (accessed May 9, 2017).
    • (2013)
  • 359
    • 85042174140 scopus 로고    scopus 로고
    • Project GENIE publicly releases large cancer genomic data set
    • (accessed May 9, 2017).
    • AACR. Project GENIE publicly releases large cancer genomic data set. http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=994#.WG5wXlPyu71, Jan 5, 2017 (accessed May 9, 2017).
    • (2017)
  • 360
    • 76649086980 scopus 로고    scopus 로고
    • National health expenditure fact sheet
    • (accessed May 23, 2017).
    • US Centers for Medicare & Medicaid Services. National health expenditure fact sheet. https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet.html (accessed May 23, 2017).
  • 361
    • 84973308480 scopus 로고    scopus 로고
    • Reimbursing wisely? CMS's trial of Medicare Part B Drug Payment Reform
    • Schrag, D, Reimbursing wisely? CMS's trial of Medicare Part B Drug Payment Reform. N Engl J Med 374 (2016), 2101–2105.
    • (2016) N Engl J Med , vol.374 , pp. 2101-2105
    • Schrag, D.1
  • 362
    • 84960860454 scopus 로고    scopus 로고
    • Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors
    • Kale, HP, Carroll, NV, Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122 (2016), 283–289.
    • (2016) Cancer , vol.122 , pp. 283-289
    • Kale, H.P.1    Carroll, N.V.2
  • 363
    • 84897019740 scopus 로고    scopus 로고
    • Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia
    • Dusetzina, SB, Winn, AN, Abel, GA, Huskamp, HA, Keating, NL, Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32 (2014), 306–311.
    • (2014) J Clin Oncol , vol.32 , pp. 306-311
    • Dusetzina, S.B.1    Winn, A.N.2    Abel, G.A.3    Huskamp, H.A.4    Keating, N.L.5
  • 364
    • 84929405050 scopus 로고    scopus 로고
    • The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer
    • Hershman, DL, Tsui, J, Meyer, J, et al. The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. J Natl Cancer Inst, 106, 2014, dju319.
    • (2014) J Natl Cancer Inst , vol.106 , pp. dju319
    • Hershman, D.L.1    Tsui, J.2    Meyer, J.3
  • 365
    • 84879256683 scopus 로고    scopus 로고
    • Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis
    • Ramsey, S, Blough, D, Kirchhoff, A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32 (2013), 1143–1152.
    • (2013) Health Aff (Millwood) , vol.32 , pp. 1143-1152
    • Ramsey, S.1    Blough, D.2    Kirchhoff, A.3
  • 366
    • 68949112230 scopus 로고    scopus 로고
    • American Society of Clinical Oncology guidance statement: the cost of cancer care
    • Meropol, NJ, Schrag, D, Smith, TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27 (2009), 3868–3874.
    • (2009) J Clin Oncol , vol.27 , pp. 3868-3874
    • Meropol, N.J.1    Schrag, D.2    Smith, T.J.3
  • 367
    • 79952139727 scopus 로고    scopus 로고
    • American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer
    • Peppercorn, JM, Smith, TJ, Helft, PR, et al. American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29 (2011), 755–760.
    • (2011) J Clin Oncol , vol.29 , pp. 755-760
    • Peppercorn, J.M.1    Smith, T.J.2    Helft, P.R.3
  • 368
    • 85011954091 scopus 로고    scopus 로고
    • Validity and reliability of value assessment frameworks for new cancer drugs
    • Bentley, TG, Cohen, JT, Elkin, EB, et al. Validity and reliability of value assessment frameworks for new cancer drugs. Value Health 20 (2017), 200–205.
    • (2017) Value Health , vol.20 , pp. 200-205
    • Bentley, T.G.1    Cohen, J.T.2    Elkin, E.B.3
  • 369
    • 84925300583 scopus 로고    scopus 로고
    • Medicare innovation center oncology care model: a toe in the water when a plunge is needed
    • Polite, BN, Miller, HD, Medicare innovation center oncology care model: a toe in the water when a plunge is needed. J Oncol Pract 11 (2015), 117–119.
    • (2015) J Oncol Pract , vol.11 , pp. 117-119
    • Polite, B.N.1    Miller, H.D.2
  • 370
    • 85014574234 scopus 로고    scopus 로고
    • Financial toxicity and societal costs of cancer care: distinct problems require distinct solutions
    • Peppercorn, J, Financial toxicity and societal costs of cancer care: distinct problems require distinct solutions. Oncologist 22 (2017), 123–125.
    • (2017) Oncologist , vol.22 , pp. 123-125
    • Peppercorn, J.1
  • 371
    • 3543094440 scopus 로고    scopus 로고
    • Racial and ethnic disparities in health care. A position paper of the American College of Physicians
    • American College of Physicians. Racial and ethnic disparities in health care. A position paper of the American College of Physicians. Ann Intern Med 141 (2004), 226–232.
    • (2004) Ann Intern Med , vol.141 , pp. 226-232
  • 374
    • 34247369412 scopus 로고    scopus 로고
    • Disparities in cancer care: challenges and solutions
    • Raghavan, D, Disparities in cancer care: challenges and solutions. Oncology 21 (2007), 493–506.
    • (2007) Oncology , vol.21 , pp. 493-506
    • Raghavan, D.1
  • 375
    • 84866873044 scopus 로고    scopus 로고
    • Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines
    • Symonds, RP, Lord, K, Mitchell, AJ, Raghavan, D, Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. Brit J Cancer 107 (2012), 1017–1021.
    • (2012) Brit J Cancer , vol.107 , pp. 1017-1021
    • Symonds, R.P.1    Lord, K.2    Mitchell, A.J.3    Raghavan, D.4
  • 376
    • 33646576857 scopus 로고    scopus 로고
    • Between and within: international perspectives on cancer and health disparities
    • Jones, LA, Chilton, JA, Hajek, RA, Iammarino, NK, Laufman, L, Between and within: international perspectives on cancer and health disparities. J Clin Oncol 24 (2006), 2204–2208.
    • (2006) J Clin Oncol , vol.24 , pp. 2204-2208
    • Jones, L.A.1    Chilton, J.A.2    Hajek, R.A.3    Iammarino, N.K.4    Laufman, L.5
  • 377
    • 80051580618 scopus 로고    scopus 로고
    • Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
    • Siegel, R, Ward, E, Brawley, O, Jemal, A, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61 (2011), 212–236.
    • (2011) CA Cancer J Clin , vol.61 , pp. 212-236
    • Siegel, R.1    Ward, E.2    Brawley, O.3    Jemal, A.4
  • 378
    • 0030587798 scopus 로고    scopus 로고
    • The medicalization of race: scientific legitimization of a flawed social construct
    • Witzig, R, The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med 125 (1996), 675–679.
    • (1996) Ann Intern Med , vol.125 , pp. 675-679
    • Witzig, R.1
  • 379
    • 0037147189 scopus 로고    scopus 로고
    • Genetic structure of human populations
    • Rosenberg, NA, Pritchard, JK, Weber, JL, et al. Genetic structure of human populations. Science 298 (2002), 2381–2385.
    • (2002) Science , vol.298 , pp. 2381-2385
    • Rosenberg, N.A.1    Pritchard, J.K.2    Weber, J.L.3
  • 380
    • 33646545050 scopus 로고    scopus 로고
    • Genetics, epidemiology, and cancer disparities: is it black and white?
    • Rebbeck, TR, Halbert, CH, Sankar, P, Genetics, epidemiology, and cancer disparities: is it black and white?. J Clin Oncol 24 (2006), 2164–2169.
    • (2006) J Clin Oncol , vol.24 , pp. 2164-2169
    • Rebbeck, T.R.1    Halbert, C.H.2    Sankar, P.3
  • 381
    • 85046525671 scopus 로고    scopus 로고
    • From the Surgeon General: eliminating global cancer disparities
    • Satcher, D, From the Surgeon General: eliminating global cancer disparities. JAMA, 284, 2000, 2864.
    • (2000) JAMA , vol.284 , pp. 2864
    • Satcher, D.1
  • 382
    • 26944473246 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer, 1975–2002, featuring population based trends in cancer treatment
    • Edwards, BK, Brown, ML, Wingo, PA, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population based trends in cancer treatment. J Natl Cancer Inst 97 (2005), 1407–1427.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1407-1427
    • Edwards, B.K.1    Brown, M.L.2    Wingo, P.A.3
  • 384
    • 84865313587 scopus 로고    scopus 로고
    • Survival disparities by Medicaid status: an analysis of 8 cancers
    • Koroukian, SM, Bakaki, P, Raghavan, D, Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer 118 (2012), 4271–4279.
    • (2012) Cancer , vol.118 , pp. 4271-4279
    • Koroukian, S.M.1    Bakaki, P.2    Raghavan, D.3
  • 385
    • 34748922923 scopus 로고    scopus 로고
    • Cancer mortality in the United States by education level and race
    • Albano, JD, Ward, E, Jemal, A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99 (2007), 1384–1394.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1384-1394
    • Albano, J.D.1    Ward, E.2    Jemal, A.3
  • 386
    • 85042183563 scopus 로고    scopus 로고
    • CMS wants to remodel cancer payment, care
    • Reinke, T, CMS wants to remodel cancer payment, care. Manag Care 25 (2016), 12–15.
    • (2016) Manag Care , vol.25 , pp. 12-15
    • Reinke, T.1
  • 387
    • 84863195517 scopus 로고    scopus 로고
    • American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology
    • Schnipper, LE, Smith, TJ, Raghavan, D, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 30 (2012), 1715–1724.
    • (2012) J Clin Oncol , vol.30 , pp. 1715-1724
    • Schnipper, L.E.1    Smith, T.J.2    Raghavan, D.3
  • 388
    • 84920920021 scopus 로고    scopus 로고
    • Tumor marker usage and medical care costs among older early-stage breast cancer survivors
    • Ramsey, SD, Henry, NL, Gralow, JR, et al. Tumor marker usage and medical care costs among older early-stage breast cancer survivors. J Clin Oncol 33 (2015), 149–155.
    • (2015) J Clin Oncol , vol.33 , pp. 149-155
    • Ramsey, S.D.1    Henry, N.L.2    Gralow, J.R.3
  • 389
    • 84919359545 scopus 로고    scopus 로고
    • Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008–2013
    • Bekelman, JE, Sylwestrzak, G, Barron, J, et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008–2013. JAMA 312 (2014), 2542–2550.
    • (2014) JAMA , vol.312 , pp. 2542-2550
    • Bekelman, J.E.1    Sylwestrzak, G.2    Barron, J.3
  • 390
    • 84920926642 scopus 로고    scopus 로고
    • The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343
    • Palta, M, Palta, P, Bhavsar, NA, Horton, JK, Blitzblau, RC, The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. Cancer 121 (2015), 188–193.
    • (2015) Cancer , vol.121 , pp. 188-193
    • Palta, M.1    Palta, P.2    Bhavsar, N.A.3    Horton, J.K.4    Blitzblau, R.C.5
  • 391
    • 84894067849 scopus 로고    scopus 로고
    • Ethical considerations for the clinical oncologist in an era of oncology drug shortages
    • Jagsi, R, Spence, R, Rathmell, WK, et al. Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist 19 (2014), 186–192.
    • (2014) Oncologist , vol.19 , pp. 186-192
    • Jagsi, R.1    Spence, R.2    Rathmell, W.K.3
  • 392
    • 85021771331 scopus 로고    scopus 로고
    • Patient financial assistance programs: a path to affordability or a barrier to accessible cancer care?
    • Zafar, SY, Peppercorn, JM, Patient financial assistance programs: a path to affordability or a barrier to accessible cancer care?. J Clin Oncol 35 (2017), 2113–2116.
    • (2017) J Clin Oncol , vol.35 , pp. 2113-2116
    • Zafar, S.Y.1    Peppercorn, J.M.2
  • 393
    • 0142058269 scopus 로고    scopus 로고
    • Cancer prevention in underserved African American communities: barriers and effective strategies. A review of the literature
    • Wolff, M, Bates, T, Beck, B, et al. Cancer prevention in underserved African American communities: barriers and effective strategies. A review of the literature. WMJ 102 (2003), 36–40.
    • (2003) WMJ , vol.102 , pp. 36-40
    • Wolff, M.1    Bates, T.2    Beck, B.3
  • 394
    • 18044403228 scopus 로고    scopus 로고
    • Recruitment and retention of minority women in cancer screening, prevention, and treatment trials
    • Brown, DR, Fouad, MN, Basen-Engquist, K, et al. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 10 (2000), S13–S21.
    • (2000) Ann Epidemiol , vol.10 , pp. S13-S21
    • Brown, D.R.1    Fouad, M.N.2    Basen-Engquist, K.3
  • 395
    • 0032531684 scopus 로고    scopus 로고
    • Prevention and control in diverse Hispanic populations: a national initiative for research and action
    • Ramirez, AG, McAlister, A, Villarreal, R, et al. Prevention and control in diverse Hispanic populations: a national initiative for research and action. Cancer 83:suppl (1998), S1825–S1829.
    • (1998) Cancer , vol.83 , pp. S1825-S1829
    • Ramirez, A.G.1    McAlister, A.2    Villarreal, R.3
  • 396
    • 16444381731 scopus 로고    scopus 로고
    • Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
    • Armstrong, K, Micco, E, Carney, A, Stopfer, J, Putt, M, Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293 (2005), 1729–1736.
    • (2005) JAMA , vol.293 , pp. 1729-1736
    • Armstrong, K.1    Micco, E.2    Carney, A.3    Stopfer, J.4    Putt, M.5
  • 398
    • 26444519200 scopus 로고    scopus 로고
    • Comorbidity and survival disparities among black and white patients with breast cancer
    • Tammemagi, CM, Nerenz, D, Neslund-Dudas, C, Feldkamp, C, Nathanson, D, Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294 (2005), 1765–1772.
    • (2005) JAMA , vol.294 , pp. 1765-1772
    • Tammemagi, C.M.1    Nerenz, D.2    Neslund-Dudas, C.3    Feldkamp, C.4    Nathanson, D.5
  • 400
    • 67649934430 scopus 로고    scopus 로고
    • American Society of Clinical Oncology policy statement—disparities in cancer care
    • Goss, E, Lopez, AM, Brown, CL, Wollins, DS, Brawley, OW, Raghavan, D, American Society of Clinical Oncology policy statement—disparities in cancer care. J Clin Oncol 27 (2009), 2881–2885.
    • (2009) J Clin Oncol , vol.27 , pp. 2881-2885
    • Goss, E.1    Lopez, A.M.2    Brown, C.L.3    Wollins, D.S.4    Brawley, O.W.5    Raghavan, D.6
  • 401
    • 84978264042 scopus 로고    scopus 로고
    • The state of lung cancer research: a global analysis
    • Aggarwal, A, Lewison, G, Idir, S, et al. The state of lung cancer research: a global analysis. J Thorac Oncol 11 (2016), 1040–1050.
    • (2016) J Thorac Oncol , vol.11 , pp. 1040-1050
    • Aggarwal, A.1    Lewison, G.2    Idir, S.3
  • 402
    • 44349145010 scopus 로고    scopus 로고
    • Rescue of salivary gland function after stem cell transplantation in irradiated glands
    • Lombaert, IM, Brunsting, JF, Wierenga, PK, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One, 3, 2008, e2063.
    • (2008) PLoS One , vol.3 , pp. e2063
    • Lombaert, I.M.1    Brunsting, J.F.2    Wierenga, P.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.